<SEC-DOCUMENT>0001104659-25-094134.txt : 20250929
<SEC-HEADER>0001104659-25-094134.hdr.sgml : 20250929
<ACCEPTANCE-DATETIME>20250929082534
ACCESSION NUMBER:		0001104659-25-094134
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20250929
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250929
DATE AS OF CHANGE:		20250929

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HELIUS MEDICAL TECHNOLOGIES, INC.
		CENTRAL INDEX KEY:			0001610853
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				364787690
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38445
		FILM NUMBER:		251352363

	BUSINESS ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940
		BUSINESS PHONE:		215-944-6100

	MAIL ADDRESS:	
		STREET 1:		642 NEWTOWN YARDLEY ROAD
		CITY:			NEWTOWN
		STATE:			PA
		ZIP:			18940

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC
		DATE OF NAME CHANGE:	20180517

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HELIUS MEDICAL TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20140613
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2527115d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:hsdt="http://heliusmedical.com/20250929">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_hsdt_heliusmedical.com_20250929 -->
<!-- Field: Set; Name: xdx; ID: xdx_043_20250929_20250929 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityCentralIndexKey_0001610853 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000005" name="dei:EntityCentralIndexKey">0001610853</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="hsdt-20250929.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-09-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001610853</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-09-29</xbrli:startDate>
        <xbrli:endDate>2025-09-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>



<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b>&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_904_edei--DocumentType_c20250929__20250929_zXo3O19RjjHj"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41.15pt 0pt 41.05pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>CURRENT</b></span><b>
REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41.1pt 0pt 41.05pt; text-align: center"><b>Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):<span id="xdx_902_edei--DocumentPeriodEndDate_c20250929__20250929_zBxgFFxNblp7">
<ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">September 29, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span>&#160;</span></b></p>

<p style="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span><b><span id="xdx_900_edei--EntityRegistrantName_c20250929__20250929_zzDOP1GQxMtd" style="text-transform: capitalize"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000012" name="dei:EntityRegistrantName">HELIUS MEDICAL TECHNOLOGIES, INC.</ix:nonNumeric>
</span></b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 41.05pt; text-align: center">(Exact name of registrant as specified
in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 75%; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt 0.25pt 1pt; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityIncorporationStateCountryCode_c20250929__20250929_zsKHfairrxhg"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="padding: 0.25pt 0.25pt 1pt; width: 33%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90D_edei--EntityFileNumber_c20250929__20250929_zLZSzppQT3q4"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000014" name="dei:EntityFileNumber">001-38445</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
    <td style="padding: 0.25pt 0.25pt 1pt; width: 33%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20250929__20250929_zmEybYwzumF5"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000015" name="dei:EntityTaxIdentificationNumber">36-4787690</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(State or other
                                jurisdiction</b></p></td>
    <td><b>&#160;</b></td>
    <td style="padding: 0.25pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission <b>File Number)</b></b></span></td><td><b>&#160;</b></td><td style="padding: 0.25pt"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(IRS
                                            Employer</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; text-align: center"><b>of incorporation)</b></td>
    <td><b>&#160;</b></td>
    <td style="padding: 0.25pt; vertical-align: top; font-size: 10pt; text-align: center"/>
    <td><b>&#160;</b></td>
    <td style="padding: 0.25pt; text-align: center"><b>Identification No.)</b></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; width: 69%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressAddressLine1_c20250929__20250929_znPOqSrNwsc5"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000016" name="dei:EntityAddressAddressLine1">642 Newtown Yardley Road</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20250929__20250929_zJeSP0OoEm67"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000017" name="dei:EntityAddressAddressLine2">Suite
    100</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20250929__20250929_zv1FGAGeSet6"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000018" name="dei:EntityAddressCityOrTown">Newtown</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250929__20250929_zGc19DzWdEG5"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000019" name="dei:EntityAddressStateOrProvince">PA</ix:nonNumeric></span></b></p></td>
    <td style="padding: 0.25pt 0.25pt 1pt 7.45pt; width: 1%">&#160;</td>
    <td style="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt; font-size: 10pt; text-align: center; width: 30%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250929__20250929_zUJuRjpdZlnl"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000020" name="dei:EntityAddressPostalZipCode">18940</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><b>(Address of principal executive offices)</b></td>
    <td style="padding: 0.25pt 0.25pt 0.25pt 7.45pt"><b>&#160;</b></td>
    <td style="padding: 0.25pt; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
    Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including area code:</b> <b>(<span id="xdx_90E_edei--CityAreaCode_c20250929__20250929_z2ChrnlAlAXj"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000021" name="dei:CityAreaCode">215</ix:nonNumeric></span></b><b>) <span id="xdx_909_edei--LocalPhoneNumber_c20250929__20250929_zUpJWCZDs8qg"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000022" name="dei:LocalPhoneNumber">944-6100</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Former name or former address, if changed since last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90C_edei--WrittenCommunications_c20250929__20250929_z39YK7npkMMj"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000023" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify">Written communications pursuant to Rule&#160;425 under the Securities
Act (17 CFR 230.425)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_900_edei--SolicitingMaterial_c20250929__20250929_zQdZv551TSP"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000024" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify">Soliciting material pursuant to Rule&#160;14a-12 under the Exchange
Act (17 CFR 240.14a-12)</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_90F_edei--PreCommencementTenderOffer_c20250929__20250929_zuJOJmhCPAdg"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under
the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Wingdings"><span id="xdx_901_edei--PreCommencementIssuerTenderOffer_c20250929__20250929_z92e3MfgXtmg"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td><td style="text-align: justify">Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under
the Exchange Act (17 CFR 240.13e-4(c))</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading <br/>
Symbol(s)</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of each exchange on which&#8239;registered</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20250929__20250929_zTMEZTTnLybh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000027" name="dei:Security12bTitle">Class&#160;A
    Common Stock, $0.001 par value</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_906_edei--TradingSymbol_c20250929__20250929_zKpt3U4BGYSd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-09-29" id="Fact000028" name="dei:TradingSymbol">HSDT</ix:nonNumeric></span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span id="xdx_907_edei--SecurityExchangeName_c20250929__20250929_zD1cpLzMCv87" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">The
    Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule&#160;12b-2
of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Emerging growth
company </span><span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250929__20250929_zLFfqBghEKJ1"><ix:nonNumeric contextRef="AsOf2025-09-29" format="ixt:booleanfalse" id="Fact000030" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act. </span><span style="font-family: Wingdings">&#168;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.03. Amendments to Articles of Incorporation or Bylaws&#894;
Change in Fiscal Year.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Change in Company Name</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">On September 25, 2025, the Board
of Directors (the &#8220;Board&#8221;) of Helius Medical Technologies, Inc. (the &#8220;Company&#8221;) approved an amendment to the Company&#8217;s
Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on July 18, 2018 (the &#8220;Certificate of
Incorporation&#8221;), to change the Company&#8217;s name to <b>Solana Company </b>(the &#8220;Name Change&#8221;). On September 26, 2025,
the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;)
to the Certificate of Incorporation, which will effect the Name Change at 8:00 a.m. Eastern Time on September 29, 2025. Pursuant to Section
242(d)(1) of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;), the Name Change did not require approval of
the Company&#8217;s stockholders and will not affect the rights of the Company&#8217;s security holders. A copy of the Certificate of Amendment
is included as <span style="text-decoration: underline">Exhibit 3.1</span> to this Current Report on Form 8-K and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">Additionally, the Board approved
an amendment to the Company&#8217;s Second Amended and Restated Bylaws solely to reflect the Name Change (the &#8220;Third Amended and
Restated Bylaws&#8221;). The Third Amended and Restated Bylaws will become effective immediately after the Name Change on September 29,
2025. In accordance with the DGCL and the provisions of the Company&#8217;s organizational documents, the Board approved the Third Amended
and Restated Bylaws, and stockholder approval was not required for such amendment. A copy of the Third Amended and Restated Bylaws is
included as <span style="text-decoration: underline">Exhibit 3.2</span> to this Current Report on Form 8-K and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Press Release</span></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">On September 29, 2025, the Company
issued a press release (the &#8220;Press Release&#8221;) to announce the Name Change, as well as the Company&#8217;s entry into a non-binding
letter of intent with the Solana Foundation (the &#8220;Foundation&#8221;) which sets forth the principal terms of HSDT&#8217;s commitment
to SOL, the Company&#8217;s future partnership with the Foundation and certain purchase option rights granted to the Company.&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">A copy of the Press Release is
included as <span style="text-decoration: underline">Exhibit 99.1</span> to this Current Report on Form 8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in; text-align: left"><b>Exhibit</b> <b>No.</b></td><td style="text-align: justify"><b>Description
                                            of Exhibits</b></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.05pt"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top">
<td style="width: 0.75in"><a href="tm2527115d1_ex3-1.htm">3.1</a></td><td style="text-align: justify"><a href="tm2527115d1_ex3-1.htm">Certificate of Amendment to the Certificate of Incorporation of Helius Medical Technologies, Inc., as
filed with the Secretary of State of the State of Delaware on September 26, 2025, and effective on September 29, 2025.</a></td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><a href="tm2527115d1_ex3-2.htm">3.2</a></td><td style="text-align: justify"><a href="tm2527115d1_ex3-2.htm">Third Amended and Restated Bylaws, effective September 29, 2025.</a></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left"><a href="tm2527115d1_ex99-1.htm" style="-sec-extract: exhibit">99.1</a></td><td style="text-align: justify"><a href="tm2527115d1_ex99-1.htm" style="-sec-extract: exhibit">Press Release, issued September 29, 2025</a></td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">104</td><td style="text-align: justify"><span style="font-style: normal; font-weight: 400; text-decoration-style: initial; text-transform: none; background-color: rgb(255, 255, 255)">Cover
Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr>
     </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td/>
    <td colspan="2"><b>HELIUS MEDICAL TECHNOLOGIES, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 45%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: September&#160;29, 2025</span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Jeffrey
S. Mathiesen</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td/>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey S. Mathiesen</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td/>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer, Treasurer and Secretary</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKwjAMRb9g/xD6LLoVBdmjY4o4ZQwRX6uLUtyakVbdPsm/tNsQQ0gI955cISZiQ2tdIcN5VWRwxLqplEMo8IaM5orekWx3Mfhd4F1bx8q44fyBCXkGPbOYSnnxwmB9aYtlDOFiFi5ncg5RFPuZ70XQ6wmZmy7ROK0qUKaEnKlhjU5xN344qpYM1d0QdUK2mkwM0TQc5Q/IMJJwoJd6Ez8sZFkigslQgdgwPRvvSluHpichrbD2cXak/x18AQeUSo4= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2527115d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit&nbsp;3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CERTIFICATE OF AMENDMENT
TO THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>CERTIFICATE OF INCORPORATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><B>OF HELIUS MEDICAL TECHNOLOGIES,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">(Pursuant to Section&nbsp;242
of the General Corporation Law of the State of Delaware)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>Helius
Medical Technologies,&nbsp;Inc.</B></FONT><B>&nbsp;</B>(the &ldquo;<B><I>Corporation</I></B>&rdquo;), a corporation organized and existing
under and by&nbsp;virtue of the General Corporation Law of the State of Delaware (the <B><I>&ldquo;DGCL&rdquo;</I></B>), does hereby certify
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt"><B>FIRST:</B></FONT>&nbsp;The
name of the Corporation is Helius Medical Technologies,&nbsp;Inc.;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt"><B>SECOND:
</B></FONT>The Corporation was incorporated under the name Helius Medical Technologies,&nbsp;Inc. pursuant to an original Certificate
of Incorporation filed with the Secretary of State of the State of Delaware on July&nbsp;18, 2018 (as previously corrected and as subsequently
amended from time to time, the &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt"><B>THIRD:</B></FONT>&nbsp;The
Board of Directors of the Corporation, acting in accordance with the provisions of Sections 141 and 242 of the DGCL, adopted resolutions
amending the Certificate of Incorporation as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">RESOLVED,
that Article&nbsp;I of the Certificate of Incorporation of the Corporation is hereby amended and restated in its entirety as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&ldquo;The
name of this corporation is Solana Company (the &ldquo;<B><I>Company</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt"><B>FOURTH:</B></FONT>&nbsp;This
Certificate of Amendment to the Certificate of Incorporation shall be effective as of 8:00&nbsp;a.m.&nbsp;Eastern time on September&nbsp;29,
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-size: 10pt; font-variant: small-caps"><B>In
Witness Whereof</B></FONT>, Helius Medical Technologies,&nbsp;Inc. has caused this Certificate of Amendment to be&nbsp;executed by its
duly authorized officer on this 25th day of&nbsp;September, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: small-caps 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Helius Medical Technologies,&nbsp;Inc.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">/s/ Jeffrey S. Mathiesen<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeffrey S. Mathiesen</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Financial Officer, Treasurer and Secretary</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>3
<FILENAME>tm2527115d1_ex3-2.htm
<DESCRIPTION>EXHIBIT 3.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIRD AMENDED AND RESTATED BYLAWS<BR>
OF<BR>
<FONT STYLE="text-transform: uppercase">SOLANA COMPANY<BR>
</FONT>(A DELAWARE CORPORATION)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; font-size: 10pt; text-align: left; width: 15%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; width: 75%">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 2%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 8%">Page</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE I Offices</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 1.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Registered Office</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 2.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Other Offices</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE II Corporate Seal</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 3.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Corporate Seal</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE III Stockholders&rsquo; Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 4.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Place of Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 5.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Annual Meeting</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 6.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Special Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">8</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 7.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Notice of Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">9</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 8.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Quorum</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 9.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Adjournment and Notice of Adjourned Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">10</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 10.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Voting Rights</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 11.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Joint Owners of Stock</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 12.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">List of Stockholders</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">11</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 13.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Action Without Meeting</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">12</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 14.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Organization</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">12</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE IV Directors</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 15.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Number</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left; width: 15%">Section 16.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 75%">Powers</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 2%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 8%">13</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 17.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Term of Directors</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 18.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Vacancies</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 19.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Resignation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">13</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 20.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Removal.</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">14</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 21.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Meetings</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">14</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 22.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Quorum and Voting</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">15</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 23.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Action Without Meeting</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">15</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 24.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Fees and Compensation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">15</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 25.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Committees</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">15</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 26.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Duties of Chairperson of the Board of Directors and Lead
    Independent Director</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">17</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 27.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Organization</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">17</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE V Officers</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">17</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 28.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Officers Designated</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">17</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 29.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Tenure and Duties of Officers</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">18</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 30.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Delegation of Authority</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">19</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 31.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Resignations</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 32.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Removal</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE VI Execution Of Corporate Instruments
    And Voting Of Securities Owned By The Corporation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 33.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Execution of Corporate Instruments</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 34.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Voting of Securities Owned by the Corporation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">20</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE VII Shares Of Stock</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">21</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 35.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Form and Execution of Certificates</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">21</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 36.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Lost Certificates</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">21</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left; width: 15%">Section 37.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 75%">Transfers</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; width: 2%">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right; width: 8%">21</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 38.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Fixing Record Dates</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">22</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 39.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Registered Stockholders</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">22</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE VIII Other Securities Of The Corporation</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">22</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 40.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Execution of Other Securities</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">22</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE IX Dividends</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 41.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Declaration of Dividends</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 42.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Dividend Reserve</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE X Fiscal Year</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 43.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Fiscal Year</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE XI Indemnification</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 44.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Indemnification of Directors, Executive Officers, Other
    Officers, Employees and Other Agents</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">23</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE XII Notices</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">27</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 45.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Notices</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">27</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE XIII Amendments</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">28</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 46.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Amendments</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">28</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">ARTICLE XIV Forum For Adjudication Of Disputes</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">28</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.375in; text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD><TD STYLE="text-align: left; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: right; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0.375in; text-align: left">Section 47.</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Forum for Adjudication of Disputes</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">28</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIRD AMENDED AND RESTATED BYLAWS<BR>
OF<BR>
<FONT STYLE="text-transform: uppercase">SOLANA COMPANY<BR>
</FONT>(A DELAWARE CORPORATION)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I<FONT STYLE="text-transform: uppercase"><U><BR>
Offices</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;1.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Registered
Office</B></FONT><B>. </B>The registered office of the corporation shall be fixed in the Certificate of Incorporation (as amended, the
 &ldquo;<B><I>Certificate of Incorporation</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;2.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Other
Offices</FONT></B>. The corporation shall also have and maintain an office or principal place of business at such place as may be fixed
by the corporation&rsquo;s board of directors (the &ldquo;<B><I>Board of Directors</I></B>&rdquo;), and may also have offices at such
other places, both within and outside of the State of Delaware as the Board of Directors may from time to time determine or the business
of the corporation may require.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II<FONT STYLE="text-transform: uppercase"><U><BR>
Corporate Seal</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;3.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Corporate
Seal</FONT></B>. The Board of Directors may adopt a corporate seal. If adopted, the corporate seal shall consist of a die bearing the
name of the corporation and the inscription, &ldquo;Corporate Seal-Delaware.&rdquo; Said seal may be used by causing it, a facsimile,
or other electronic means thereof to be impressed or affixed or reproduced or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III<FONT STYLE="text-transform: uppercase"><U><BR>
Stockholders&rsquo; Meetings</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;4.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Place
of Meetings</FONT></B>. Meetings of the stockholders of the corporation may be held at such place, either within or outside of the State
of Delaware, as may be determined from time to time by the Board of Directors. The Board of Directors may, in its sole discretion, determine
that the meeting shall not be held at any place, but may instead be held solely by means of remote communication as provided under the
Delaware General Corporation Law (the &ldquo;<B><I>DGCL</I></B>&rdquo;), or that stockholders not physically present at a meeting of
stockholders may, by means of remote communication, participate in the meeting and be deemed to be present in person and vote at the
meeting, whether such meeting is to be held at a designated place or solely by means of remote communication, subject to such guidelines
and procedures as the Board of Directors may adopt in accordance with the requirements of applicable law and the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;5.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;
 &#8239;&#8239;&#8239;&#8239; &#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Annual Meetings</FONT></B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
annual meeting of the stockholders of the corporation, for the purpose of election of directors and for such other business as shall
properly come before it in accordance with these Second Amended and Restated Bylaws (the &ldquo;<B><I>Bylaws</I></B>&rdquo;), shall be
held on such date and at such time as may be designated from time to time by the Board of Directors. Nominations of persons for election
to the Board of Directors of the corporation and the proposal of business to be considered by the stockholders may be made at an annual
meeting of stockholders: (i)&nbsp;pursuant to the corporation&rsquo;s notice of meeting of stockholders (with respect to business other
than nominations); (ii)&nbsp;brought specifically by or at the direction of the Board of Directors; or (iii)&nbsp;by any stockholder
of the corporation who was a stockholder of record at the time of giving the stockholder&rsquo;s notice provided for in <U>Section&nbsp;5(b)</U>&nbsp;below,
at the record date for the meeting and at the time of the meeting, who is entitled to vote at the meeting and who complied with the notice
procedures and other provisions and requirements set forth in this <U>Section&nbsp;5</U> (a &ldquo;<B><I>Notifying Stockholder</I></B>&rdquo;).
For the avoidance of doubt, clause (iii)&nbsp;above shall be the exclusive means for a stockholder to make nominations and submit other
business (other than matters properly included in the corporation&rsquo;s notice of meeting of stockholders and proxy statement under
Rule&nbsp;14a-8 under the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations thereunder (the &ldquo;<B><I>1934
Act</I></B>&rdquo;)) before an annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>At
an annual meeting of the stockholders, only such business shall be conducted as is a proper matter for stockholder action under the DGCL
and as shall have been properly brought before the meeting in accordance with the procedures set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>For
nominations for the election to the Board of Directors to be properly brought before an annual meeting by a Notifying Stockholder pursuant
to clause (iii)&nbsp;of <U>Section&nbsp;5(a)</U>, the Notifying Stockholder must deliver written notice to the Secretary of the corporation
at the principal executive offices of the corporation on a timely basis as set forth in <U>Section&nbsp;5(b)(iii)</U>&nbsp;and must update
and supplement such written notice on a timely basis as set forth in <U>Section&nbsp;5(c)</U>. Such Notifying Stockholder&rsquo;s notice
shall set forth: (A)&nbsp;as to each nominee such Notifying Stockholder proposes to nominate at the meeting: (1)&nbsp;the name, age,
business address and residence address of such nominee; (2)&nbsp;the principal occupation or employment of such nominee and a description
of the qualifications and business or professional experience of each proposed nominee; (3)&nbsp;a description of any position of such
nominee as an executive officer or director of any principal competitor (as defined below) of the corporation within the three years
preceding the submission of the notice; (4)&nbsp;the class and number of shares of each class of capital stock or other securities of
the corporation which are owned of record and beneficially by such nominee; (5)&nbsp;the date or dates on which such securities were
acquired and the investment intent of such acquisition; (6)&nbsp;a description of all Derivative Transactions (as defined below) by each
nominee during the previous twelve month period, including the date of the transactions and the class, series and number of securities
involved in, and the material economic terms of, such Derivative Transactions; (7)&nbsp;a description of any business or personal interests
that could place such nominee in a potential conflict of interest with the Corporation or any of its subsidiaries; (8)&nbsp;a written
representation and agreement, in the form provided by the Secretary upon written request of the Notifying Stockholder, which shall include
the representations and agreements described in <U>Section&nbsp;5(e)</U>, within five business days of such written request, that such
nominee (I)&nbsp;if elected, intends to tender promptly following such person&rsquo;s failure to receive the required vote for election
or re-election at the next meeting at which such person would face election or re-election, an irrevocable resignation effective upon
acceptance of such resignation by the Board of Directors, (II)&nbsp;agrees to be named as a nominee in a proxy statement and proxy card
relating to such meeting of stockholders, (III)&nbsp;agrees to serve as a director for the full term for which such person is standing
for election, if elected, (IV)&nbsp;would be in compliance with and will comply with all of the corporation&rsquo;s publicly-available
corporate governance, policies and guidelines applicable to directors, and (V)&nbsp;agrees to comply with all applicable rules&nbsp;or
regulations of any stock exchange applicable to the corporation; and (9)&nbsp;such other information concerning such nominee as would
be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest
(even if an election contest is not involved), or that is otherwise required to be disclosed pursuant to Section&nbsp;14 of the 1934
Act and the rules&nbsp;and regulations promulgated thereunder including, without limitation, Regulation 14A and Rule&nbsp;14a-19, and
such nominee&rsquo;s written consent to the corporation&rsquo;s public disclosure of the foregoing; and (B)&nbsp;the information required
by <U>Section&nbsp;5(b)(iv)</U>. Such notice must be accompanied by the completed and signed written questionnaire with respect to the
background and qualifications of such nominee in accordance with <U>Section&nbsp;5(e)</U>&nbsp;(which questionnaire shall be in the form
provided by the Secretary of the corporation upon written request within five business days of such request). The corporation may require
any proposed nominee to furnish such other information as it may reasonably require to determine the eligibility of such proposed nominee
to serve as an independent director of the corporation under the listing standards of the principal U.S. exchange upon which the corporation&rsquo;s
capital stock is listed, any applicable rules&nbsp;of the Securities and Exchange Commission and publicly disclosed standards, if any,
used by the Board of Directors in determining the independence of the corporation&rsquo;s directors or that could be material to a reasonable
stockholder&rsquo;s understanding of the independence, or lack thereof, of such proposed nominee. In addition, the Board of Directors
may require any proposed nominee to submit to interviews with the Board of Directors or any committee thereof, and such nominee will
make themselves available for any such interviews within ten (10)&nbsp;days following any reasonable request therefor from the Board
of Directors or any committee thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Other
than proposals sought to be included in the corporation&rsquo;s proxy materials pursuant to Rule&nbsp;14a-8 under the 1934 Act, for business
other than nominations for the election to the Board of Directors to be properly brought before an annual meeting by a stockholder pursuant
to clause (iii)&nbsp;of <U>Section&nbsp;5(a)</U>, the Notifying Stockholder must deliver written notice to the Secretary of the corporation
at the principal executive offices of the corporation on a timely basis as set forth in <U>Section&nbsp;5(b)(iii)</U>, and must update
and supplement such written notice on a timely basis as set forth in <U>Section&nbsp;5(c)</U>. Such Notifying Stockholder&rsquo;s notice
shall set forth: (A)&nbsp;as to each matter such stockholder proposes to bring before the meeting, a reasonably brief description of
the business desired to be brought before the meeting, the reasons for conducting such business at the meeting, the text of the proposal
or business (including the text of any resolutions proposed for consideration and in the event that such business includes a proposal
to amend these Bylaws, the Certificate of Incorporation or any other instrument or document, the language of the proposed amendment),
and any material interest including any anticipated benefit of such business to any Proponent (as defined below) other than solely as
a result of its ownership of the corporation&rsquo;s capital stock, that is material to any Proponent individually, or to the Proponents
in the aggregate; and (B)&nbsp;the information required by <U>Section&nbsp;5(b)(iv)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>To
be timely, the written notice required by <U>Section&nbsp;5(b)(i)</U>&nbsp;or <U>Section&nbsp;5(b)(ii)</U>&nbsp;must be received by the
Secretary of the corporation at the principal executive offices of the corporation not later than the close of business on the ninetieth
(90<FONT STYLE="font-size: 10pt">th</FONT>) day nor earlier than the close of business on the one hundred twentieth (120<FONT STYLE="font-size: 10pt">th</FONT>)
day prior to the first anniversary of the preceding year&rsquo;s annual meeting; <I>provided, however,</I> that, subject to the last
sentence of this <U>Section&nbsp;5(b)(iii)</U>, in the event that the date of the annual meeting is advanced more than thirty (30) days
prior to or delayed by more than thirty (30) days after the anniversary of the preceding year&rsquo;s annual meeting, notice by the Notifying
Stockholder to be timely must be so received no earlier than the close of business on the one hundred twentieth (120<FONT STYLE="font-size: 10pt">th</FONT>)
day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90<FONT STYLE="font-size: 10pt">th</FONT>)
day prior to such annual meeting or the close of business on the tenth (10<FONT STYLE="font-size: 10pt">th</FONT>) day following the
day on which public announcement of the date of such meeting is first made. In no event shall an adjournment, recess, judicial stay,
rescheduling or postponement of an annual meeting for which notice has been given, or the public announcement thereof has been made,
commence a new time period (or extend any time period) for the giving of a stockholder&rsquo;s notice as described above. The number
of nominees a stockholder may nominate for election at a meeting of the stockholders shall not exceed the number of directors to be elected
at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
written notice required by <U>Section&nbsp;5(b)(i)</U>&nbsp;or <U>Section&nbsp;5(b)(ii)</U>&nbsp;shall also set forth, as of the date
of the notice and as to the Notifying Stockholder and the beneficial owner, if any, and any person or entity acting in concert with the
Notifying Stockholder, or on whose behalf the nomination or proposal is made (each, a &ldquo;<B><I>Proponent</I></B>&rdquo; and collectively,
the &ldquo;<B><I>Proponents</I></B>&rdquo;): (A)&nbsp;the name and address of each Proponent, including, if applicable, their name and
address as they appear on the corporation&rsquo;s books, if different; (B)&nbsp;the class, series and number of shares of each class
of capital stock or other securities of the corporation that are, directly or indirectly, owned beneficially and of record by each Proponent
(within the meaning of Rule&nbsp;13d-3 under the 1934 Act, except that beneficially owned shall include any shares of stock or other
securities of the corporation as to which a person has a right to acquire beneficial ownership at any time in the future); (C)&nbsp;a
description of any agreement, arrangement or understanding (whether oral or in writing) with respect to such nomination or proposal between
or among any Proponent and any of its affiliates or associates, and any others (including their names) acting in concert, or otherwise
under the agreement, arrangement or understanding, with any of the foregoing; (D)&nbsp;a representation that the Proponents are holders
of record or beneficial owners, as the case may be, of shares of the corporation entitled to vote at the meeting and intend to appear
in person or by proxy at the meeting to nominate the person or persons specified in the notice (with respect to a notice under <U>Section&nbsp;5(b)(i)</U>)
or to propose the business that is specified in the notice (with respect to a notice under <U>Section&nbsp;5(b)(ii)</U>); (E)&nbsp;a
representation as to whether the Proponents or any of them intend to, or are a part of a group that intends to, (I)&nbsp;deliver a proxy
statement and/or form of proxy to at least the number of holders of the corporation&rsquo;s voting shares reasonably believed by the
Proponents to be sufficient to approve or adopt the business to be proposed or to elect such nominee or nominees, as applicable, and,
if required by Rule&nbsp;14a-19 under the 1934 Act (or a successor rule), to solicit proxies in support of director nominees other than
the corporation&rsquo;s nominees in accordance with Rule&nbsp;14a-19 under the 1934 Act (or a successor rule), (II)&nbsp;engage in a
solicitation (within the meaning of Rule&nbsp;14a-1(l)&nbsp;under the 1934 Act) with respect to the nomination, or other business, as
applicable, and if so, the name of each participant (as defined in Item 4 of Schedule 14A under the 1934 Act) in such solicitation, or
(III)&nbsp;otherwise to solicit proxies from stockholders in support of such nomination; (F)&nbsp;to the extent known by any Proponent,
the name and address of any other stockholder providing financial support or meaningful assistance in furtherance of the proposal or
the nomination, as applicable, on the date of the Notifying Stockholder&rsquo;s notice; (G)&nbsp;a description of all Derivative Transactions
(as defined below) by each Proponent during the previous twelve (12) month period, including the date of the transactions and the class,
series and number of securities involved in, and the material economic terms of, such Derivative Transactions; (H)&nbsp;any other information
relating to the Proponents, if any, that would be required to be disclosed in a proxy statement or other filings required to be made
in connection with solicitations of proxies for, as applicable, the proposal and/or for the election of directors in an contested election
pursuant to Section&nbsp;14 of the 1934 Act and the rules&nbsp;and regulations promulgated thereunder; (I)&nbsp;any material interest
of the Proponents in the proposed business and/or the election of directors described in the notice; and (J)&nbsp;a description of any
 &ldquo;participants&rdquo; (as such term is used in Rule&nbsp;13d-5 under the 1934 Act, or any successor rule), any associates, family
members living in the same household of the Notifying Stockholder and any person or entity who is a member of a &ldquo;group&rdquo; (as
such term is used in Rule&nbsp;13d-5 under the 1934 Act, or any successor rule) with the Notifying Stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>A
Notifying Stockholder providing written notice required by <U>Section&nbsp;5(b)(i)</U>&nbsp;or <U>Section&nbsp;5(b)(ii)</U>&nbsp;shall
(A)&nbsp;update and supplement such notice in writing, if necessary, so that the information provided or required to be provided in such
notice is true and correct in all material respects as of (i)&nbsp;the record date for the meeting and (ii)&nbsp;the date that is five
(5)&nbsp;business days prior to the meeting and, in the event of any adjournment or postponement thereof, five (5)&nbsp;business days
prior to such adjourned or postponed meeting; and (B)&nbsp;if a Notifying Stockholder has provided notice pursuant to <U>Section&nbsp;5(b)(i)</U>,
notify the corporation if (i)&nbsp;the Notifying Stockholder no longer intends to solicit proxies in support of director nominees other
than the corporation&rsquo;s nominees in accordance with Rule&nbsp;14a-19 under the 1934 Act (or a successor rule) or (ii)&nbsp;the Notifying
Stockholder fails to comply with the requirements of Rule&nbsp;14a-19 under the 1934 Act (or a successor rule) or any other rule&nbsp;or
regulation thereunder (such Notifying Stockholder or a related Proponent shall promptly notify the corporation of such failure), including
the provision to the corporation of notices required thereunder in a timely manner, or fail to timely provide reasonable evidence sufficient
to satisfy the corporation that the Notifying Stockholder has met the requirements of Rule&nbsp;14a-19(a)(3)&nbsp;under the 1934 Act
(or a successor rule) pursuant to the second following sentence; if any of the events described in this clause (B)&nbsp;occur or the
related notices are provided, then the corporation shall disregard any proxies or votes solicited for such proposed nominee, the nomination
of such proposed nominee will be disregarded and no vote on the election of such proposed nominee will occur (notwithstanding that proxies
in respect of such proposed nominee may have been received by the corporation). In the case of an update and supplement pursuant to clause
(A)(i)&nbsp;of this <U>Section&nbsp;5(c)</U>, such update and supplement shall be received by the Secretary of the corporation at the
principal executive offices of the corporation not later than five (5)&nbsp;business days after the record date for the meeting. In the
case of an update and supplement pursuant to clause (A)(ii)&nbsp;of this <U>Section&nbsp;5(c)</U>, such update and supplement shall be
received by the Secretary of the corporation at the principal executive offices of the corporation not later than two (2)&nbsp;business
days prior to the date for the meeting, and, in the event of any adjournment or postponement thereof, two (2)&nbsp;business days prior
to such adjourned or postponed meeting. If any Notifying Stockholder provides notice pursuant to Rule&nbsp;14a-19 under the 1934 Act
(or a successor rule), such Notifying Stockholder or a related Proponent will deliver to the Secretary, no later than five (5)&nbsp;business
days prior to the applicable meeting date, reasonable evidence that the requirements of Rule&nbsp;14a-19(a)(3)&nbsp;under the 1934 Act
(or a successor rule) have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Notwithstanding
anything in <U>Section&nbsp;5(b)(iii)</U><B>&nbsp;</B>to the contrary, in the event that the number of directors in an Expiring Class&nbsp;(as
defined below) is increased and there is no public announcement of the appointment of a director to such class, or, if no appointment
was made, of the vacancy in such class, made by the corporation at least ten (10)&nbsp;days before the last day a stockholder may deliver
a notice of nomination in accordance with <U>Section&nbsp;5(b)(iii)</U>, a Notifying Stockholder&rsquo;s notice required by this <U>Section&nbsp;5</U>
and which complies with the requirements in <U>Section&nbsp;5(b)(i)</U>, other than the timing requirements in <U>Section&nbsp;5(b)(iii)</U>,
shall also be considered timely, but only with respect to nominees for any new positions in such Expiring Class&nbsp;created by such
increase, if it shall be received by the Secretary of the corporation at the principal executive offices of the corporation not later
than the close of business on the tenth (10th) day following the day on which such public announcement is first made by the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>A
person shall not be eligible for election or re-election as a director unless the person (A)&nbsp;is nominated either in accordance with
clause (ii)&nbsp;of <U>Section&nbsp;5(a)</U>, or (B)&nbsp;is nominated in accordance with clause (iii)&nbsp;of <U>Section&nbsp;5(a)</U>&nbsp;and
has delivered to the Secretary of the corporation a completed and signed written questionnaire with respect to the background and qualification
of such proposed nominee and the background of any other person or entity on whose behalf the nomination is being made (which questionnaire
shall be in the form provided by the Secretary of the corporation upon written request) and a written representation and agreement (in
the form provided by the Secretary of the corporation upon written request) that such person: (i)&nbsp;is not and will not become a party
to (A)&nbsp;any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person or entity
as to how such person, if elected as a director of the corporation, will act or vote on any issue or question (a &ldquo;<B><I>Voting
Commitment</I></B>&rdquo;) that has not been disclosed to the corporation in the questionnaire or (B)&nbsp;any Voting Commitment that
could limit or interfere with such person&rsquo;s ability to comply, if elected as a director of the corporation, with such person&rsquo;s
fiduciary duties under applicable law; (ii)&nbsp;is not and will not become a party to any agreement, arrangement or understanding with
any person or entity other than the corporation with respect to any direct or indirect compensation, reimbursement or indemnification
in connection with service or action as a director of the corporation that has not been disclosed to the corporation in such representation
and agreement, (iii)&nbsp;in such person&rsquo;s individual capacity and on behalf of any person or entity on whose behalf the nomination
is being made, would be in compliance, if elected as a director of the corporation, and will comply with, all applicable publicly disclosed
corporate governance, conflict of interest, confidentiality, Regulation FD, code of conduct and ethics, and stock ownership and trading
policies and guidelines of the corporation, and (iv)&nbsp;will make such other acknowledgments, enter into such agreements and provide
such information as the Board of Directors requires of all directors, including promptly submitting all completed and signed questionnaires
required of the corporation&rsquo;s directors. Except as otherwise required by law, the chairperson of the meeting shall have the power
and duty to determine whether a nomination or any business proposed to be brought before the meeting was made, or proposed, as the case
may be, in accordance with the procedures set forth in these Bylaws and, if any proposed nomination or business is not in compliance
with these Bylaws, or the Notifying Stockholder and its related Proponents do not act in accordance with the representations required
in these Bylaws, including those in <U>Section&nbsp;5(b)(iv)(D)</U>&nbsp;and <U>Section&nbsp;5(b)(iv)(E)</U>, and Rule&nbsp;14a-19 under
the 1934 Act (or a successor rule), to declare that such proposal or nomination shall not be presented for stockholder action at the
meeting and shall be disregarded and that such proposed business shall not be considered or transacted, notwithstanding that proxies
in respect of such nominations or such business may have been solicited or received by the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Notwithstanding
the foregoing provisions of this <U>Section&nbsp;5</U>, in order to include information with respect to a stockholder proposal in the
proxy statement and form of proxy for a stockholders&rsquo; meeting, a stockholder must also comply with all applicable requirements
of state and federal law, including the 1934 Act and the rules&nbsp;and regulations thereunder, the Certificate of Incorporation and
these Bylaws. Notwithstanding the provisions of <U>Section&nbsp;5</U>, unless otherwise required by law, no stockholder shall solicit
proxies in support of director nominees other than the corporation&rsquo;s nominees unless such stockholder has complied with Rule&nbsp;14a-19
(or a successor rule) under the 1934 Act in connection with the solicitation of such proxies, including the provision to the corporation
of notices required thereunder in a timely manner. Nothing in these Bylaws shall be deemed to affect any rights of stockholders to request
inclusion of proposals in the corporation&rsquo;s proxy statement pursuant to Rule&nbsp;14a-8 under the 1934 Act; <I>provided, however,
</I>that any references in these Bylaws to the 1934 Act or the rules&nbsp;and regulations thereunder are not intended to and shall not
limit the requirements applicable to proposals and/or nominations to be considered pursuant to <U>Section&nbsp;5(a)(iii)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>For
the purposes of <U>Section&nbsp;5</U> and <U>Section&nbsp;6</U>,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>&ldquo;<B><I>affiliates</I></B>&rdquo;
and &ldquo;<B><I>associates</I></B>&rdquo; shall have the meanings set forth in Rule&nbsp;405 under the Securities Act of 1933, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>&ldquo;<B><I>Derivative
Transaction</I></B>&rdquo; shall mean any agreement, arrangement, interest or understanding entered into by, or on behalf or for the
benefit of, any Proponent or any nominee, as applicable, whether record or beneficial:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the value of which is derived in whole or
                                            in part from the value of any class or series of shares or other securities of the corporation,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">which otherwise provides any direct or indirect
                                            opportunity to gain or share in any gain derived from a change in the value of securities
                                            of the corporation,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the effect or intent of which is to mitigate
                                            loss, manage risk or benefit of security value or price changes, or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 2in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">which provides the right to vote or increase
                                            or decrease the voting power of, such Proponent or nominee, as applicable, or any of its
                                            affiliates or associates, with respect to any securities of the corporation,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">which agreement, arrangement, contract, interest
or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation
right, short position, repurchase, profit interest, hedge, right to dividends, voting agreement, performance-related fee or arrangement
to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any
proportionate interest of such Proponent or nominee, as applicable, in the securities of the corporation held by any general or limited
partnership, or any limited liability company, of which such Proponent or nominee, as applicable, is, directly or indirectly, a general
partner or managing member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>&ldquo;<B><I>Expiring
Class</I></B>&rdquo; shall mean a class of directors whose term shall expire at the next annual meeting of stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>&ldquo;<B><I>principal
competitor</I></B>&rdquo; shall mean any entity that develops or provides products or services that compete with or are alternatives
to the principal products developed or produced or services provided by the corporation or its affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(v)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>&ldquo;<B><I>public
announcement</I></B>&rdquo; shall mean disclosure in a press release reported by the Dow Jones News Service, Associated Press or comparable
national news service or in a document publicly filed by the corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13,
14 or 15(d)&nbsp;of the 1934 Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;6.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Special
Meetings</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Special
meetings of the stockholders of the corporation may be called, for any purpose as is a proper matter for stockholder action under the
DGCL, by (i)&nbsp;the Chairperson of the Board of Directors, (ii)&nbsp;the Chief Executive Officer, or (iii)&nbsp;the Board of Directors
pursuant to a resolution adopted by a majority of the total number of authorized directors (whether or not there exist any vacancies
in previously authorized directorships at the time any such resolution is presented to the Board of Directors for adoption).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
Board of Directors shall determine the date, time and place, if any, of such special meeting. Upon determination of the date, time and
place, if any, of the meeting, the Secretary of the corporation shall cause a notice of meeting to be given to the stockholders entitled
to vote, in accordance with the provisions of <U>Section&nbsp;7</U>. No business may be transacted at a special meeting other than as
specified in the corporation&rsquo;s notice of meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Nominations
of persons for election to the Board of Directors may only be made at a special meeting of stockholders at which directors are to be
elected pursuant to the corporation&rsquo;s notice of meeting (i)&nbsp;by or at the direction of the Board of Directors or (ii)&nbsp;by
one or more stockholders of the corporation, holding shares in the aggregate entitled to cast not less than 10% of the votes at that
meeting, who are stockholders of record at the time of giving notice provided for in this paragraph, at the record date for the meeting
and at the time of the meeting, who shall be entitled to vote at the meeting and shall deliver written notice to the Secretary of the
corporation setting forth the information required by <U>Section&nbsp;5(b)(i)</U>&nbsp;and <U>Section&nbsp;5(b)(iv)</U>, and otherwise
comply with the procedures and other requirements of this <U>Section&nbsp;6</U>. In the event the corporation calls a special meeting
of stockholders for the purpose of electing one or more directors to the Board of Directors, any such stockholder of record may nominate
a person or persons (as the case may be), for election to such position(s)&nbsp;as specified in the corporation&rsquo;s notice of meeting,
if written notice setting forth the information required by <U>Section&nbsp;5(b)(i)</U>&nbsp;shall be received by the Secretary of the
corporation at the principal executive offices of the corporation not later than the close of business on the later of the ninetieth
(90<FONT STYLE="font-size: 10pt">th</FONT>) day prior to such meeting or the tenth (10<FONT STYLE="font-size: 10pt">th</FONT>) day following
the day on which public announcement is first made of the date of the special meeting and of the nominees proposed by the Board of Directors
to be elected at such meeting. The stockholder shall also update and supplement such information as required under <U>Section&nbsp;5(c).</U>
In no event shall an adjournment, recess, judicial stay, rescheduling or postponement of a special meeting for which notice has been
given, or the public announcement thereof has been made, commence a new time period (or extend any time period) for the giving of a stockholder&rsquo;s
notice as described above. The number of nominees a stockholder may nominate for election at a special meeting of the stockholders shall
not exceed the number of directors to be elected at such meeting. If the corporation shall subsequently increase the number of directors
subject to election at the applicable meeting, such notice as to any additional nominees shall be due on the later of (x)&nbsp;the conclusion
of the time period provided for in this subsection (c)&nbsp;above or (y)&nbsp;the tenth (10th) day following the date of public announcement
of such increase.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Except
as otherwise required by law, the chairperson of the meeting shall have the power and duty to determine whether a nomination was made
in accordance with the procedures set forth in these Bylaws and, if any proposed nomination is not in compliance with these Bylaws, or
the Notifying Stockholder does not act in accordance with the representations required in these Bylaws, including those in <U>Section&nbsp;5(b)(iv)(D)</U>&nbsp;and
<U>Section&nbsp;5(b)(iv)(E)</U>, and Rule&nbsp;14a-19 (or a successor rule) under the 1934 Act, to declare that such nomination shall
not be presented for stockholder action at the special meeting and shall be disregarded, notwithstanding that proxies in respect of such
nominations may have been solicited or received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Notwithstanding
the foregoing provisions of this <U>Section&nbsp;6</U>, a Notifying Stockholder must also comply with all applicable requirements of
the state and federal law, including the 1934 Act and the rules&nbsp;and regulations thereunder, the Certificate of Incorporation and
these Bylaws, with respect to matters set forth in this <U>Section&nbsp;6</U>. Notwithstanding the provisions of this <U>Section&nbsp;6</U>,
unless otherwise required by law, no Notifying Stockholder or related Proponent shall solicit proxies in support of director nominees
other than the corporation&rsquo;s nominees unless such Notifying Stockholder and its related Proponent(s)&nbsp;have complied with Rule&nbsp;14a-19
(or a successor rule) under the 1934 Act in connection with the solicitation of such proxies, including the provision to the corporation
of notices required thereunder in a timely manner. Nothing in these Bylaws shall be deemed to affect any rights of stockholders to request
inclusion of proposals in the corporation&rsquo;s proxy statement pursuant to Rule&nbsp;14a-8 under the 1934 Act; <I>provided, however,
</I>that any references in these Bylaws to the 1934 Act or the rules&nbsp;and regulations thereunder are not intended to and shall not
limit the requirements applicable to nominations for the election to the Board of Directors to be considered pursuant to <U>Section&nbsp;6(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;7.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Notice
of Meetings</FONT>. </B>Except as otherwise provided by law, notice, given in writing or by electronic transmission, of each meeting
of stockholders shall be given not less than ten (10)&nbsp;nor more than sixty (60) days before the date of the meeting to each stockholder
entitled to vote at such meeting, such notice to specify the place, if any, date and hour, in the case of special meetings, the purpose
or purposes of the meeting, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to
be present in person and vote at any such meeting and the record date for determining the stockholders entitled to vote at the meeting,
if such date is different from the record date for determining stockholders entitled to notice of the meeting. If mailed, notice is deemed
given when deposited in the United States mail, postage prepaid, directed to the stockholder at such stockholder&rsquo;s address as it
appears on the records of the corporation. If sent via electronic transmission, notice is deemed given as of the sending time recorded
at the time of transmission. Notice of the time, place, if any, and purpose of any meeting of stockholders (to the extent required) may
be waived in writing, signed by the person entitled to notice thereof, or by electronic transmission by such person, either before or
after such meeting, and will be waived by any stockholder by such person&rsquo;s attendance thereat in person, by remote communication,
if applicable, or by proxy, except when the stockholder attends a meeting for the express purpose of objecting, at the beginning of the
meeting, to the transaction of any business because the meeting is not lawfully called or convened. Any stockholder so waiving notice
of such meeting shall be bound by the proceedings of any such meeting in all respects as if due notice thereof had been given. The Board
of Directors may postpone, reschedule or cancel any meeting of stockholders previously scheduled by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;8.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Quorum
and Required Vote.</B></FONT> At all meetings of stockholders, except where otherwise provided by law, by the Certificate of Incorporation,
or by these Bylaws, the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of one-third
of the voting power of the outstanding shares of stock entitled to vote shall constitute a quorum for the transaction of business. In
the absence of a quorum, any meeting of stockholders may be adjourned, from time to time, either by the chairperson of the meeting or
by vote of the holders of a majority of the voting power of the shares represented thereat, but no other business shall be transacted
at such meeting. The stockholders present at a duly called or convened meeting, at which a quorum is present, may continue to transact
business until adjournment, notwithstanding the withdrawal of enough stockholders to leave less than a quorum. Except as otherwise provided
by law or by applicable stock exchange rules, or by the Certificate of Incorporation or these Bylaws, in all matters other than the election
of directors, the affirmative vote of the holders of a majority of the voting power of the shares present in person, by remote communication,
if applicable, or represented by proxy duly authorized at the meeting and entitled to vote on the subject matter shall be the act of
the stockholders. Except as otherwise provided by law, or by applicable stock exchange rules, the Certificate of Incorporation or these
Bylaws, directors shall be elected by a plurality of the votes of the shares present in person, by remote communication, if applicable,
or represented by proxy duly authorized at the meeting and entitled to vote on the election of directors. Where a separate vote by a
class or classes or series is required, except where otherwise provided by law, or by applicable stock exchange rules, or by the Certificate
of Incorporation or these Bylaws, a majority of the voting power of the outstanding shares of such class or classes or series, present
in person, by remote communication, if applicable, or represented by proxy duly authorized, shall constitute a quorum entitled to take
action with respect to that vote on that matter. Except where otherwise provided by law, or by applicable stock exchange rules, or by
the Certificate of Incorporation or these Bylaws, the affirmative vote of the holders of a majority (plurality, in the case of the election
of directors) of shares of such class or classes or series present in person, by remote communication, if applicable, or represented
by proxy at the meeting shall be the act of such class or classes or series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;9.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Adjournment
and Notice of Adjourned Meetings</B></FONT><B>. </B>Any meeting of stockholders, whether annual or special, may be adjourned from time
to time, whether or not a quorum is present at the meeting, either by the chairperson of the meeting or by the vote of the holders of
a majority of the voting power of the shares present in person, by remote communication, if applicable, or represented by proxy duly
authorized at the meeting. When a meeting is adjourned (including an adjournment taken to address a technical failure to convene or continue
a meeting using remote communication) to another time or place, if any, notice need not be given of the adjourned meeting if the time
and place, if any, of such adjourned meeting, and the means of remote communications, if any, by which stockholders and proxy holders
may be deemed to be present in person and vote at such adjourned meeting are announced (i)&nbsp;at the meeting at which the adjournment
is taken, (ii)&nbsp;displayed during the time scheduled for the meeting, on the same electronic network used to enable stockholders and
proxy holders to participate in the meeting by means of remote communication, or (iii)&nbsp;set forth in the notice of meeting given
in accordance with these Bylaws. At the adjourned meeting, the corporation may transact any business that might have been transacted
at the original meeting. If the adjournment is for more than thirty (30) days or if after the adjournment a new record date is fixed
for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder of record entitled to vote at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;10.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Voting
Rights</B></FONT>. For the purpose of determining those stockholders entitled to vote on the subject matter at any meeting of the stockholders,
except as otherwise provided by law, only persons in whose names shares stand on the stock records of the corporation on the record date,
as provided in <U>Section&nbsp;12</U>, shall be entitled to vote at any meeting of stockholders. Every person entitled to vote shall
have the right to do so either in person, by remote communication, if applicable, or by an agent or agents authorized by a proxy granted
in accordance with the DGCL. An agent so appointed need not be a stockholder. No proxy shall be voted after three (3)&nbsp;years from
its date of creation unless the proxy provides for a longer period. Such a proxy may be prepared, transmitted and delivered in any manner
permitted by applicable law, including Rule&nbsp;14a-19 promulgated under the 1934 Act. Any stockholder directly or indirectly soliciting
proxies from other stockholders must use a proxy card color other than white, which shall be reserved for the exclusive use by the Board
of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;11.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Joint
Owners of Stock</B></FONT>. If shares or other securities having voting power stand of record in the names of two (2)&nbsp;or more persons,
whether fiduciaries, members of a partnership, joint tenants, tenants in common, tenants by the entirety, or otherwise, or if two (2)&nbsp;or
more persons have the same fiduciary relationship respecting the same shares, unless the Secretary of the corporation is given written
notice to the contrary and is furnished with a copy of the instrument or order appointing them or creating the relationship wherein it
is so provided, their acts with respect to voting shall have the following effect: (a)&nbsp;if only one (1)&nbsp;votes, such act binds
all; (b)&nbsp;if more than one (1)&nbsp;votes, the act of the majority so voting binds all; (c)&nbsp;if more than one (1)&nbsp;votes,
but the vote is evenly split on any particular matter, each faction may vote the securities in question proportionally, or may apply
to the Delaware Court of Chancery for relief as provided in Section&nbsp;217(b)&nbsp;of the DGCL. If the instrument filed with the Secretary
shows that any such tenancy is held in unequal interests, a majority or even-split for the purpose of subsection (c)&nbsp; of this <U>Section&nbsp;11</U>
shall be a majority or even-split in interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;12.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>List
of Stockholders</B></FONT>. The corporation shall prepare, no later than the tenth day before each meeting of stockholders, a complete
list of the stockholders entitled to vote at said meeting, arranged in alphabetical order, showing the address of each stockholder and
the number and class of shares registered in the name of each stockholder. Such list shall be open to the examination of any stockholder,
for any purpose germane to the meeting for a period of ten days ending on the day before the meeting date, (a)&nbsp;on a reasonably accessible
electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or
(b)&nbsp;during ordinary business hours, at the principal place of business of the corporation. In the event that the corporation determines
to make the list available on an electronic network, the corporation may take reasonable steps to ensure that such information is available
only to stockholders of the corporation. Except as otherwise provided by law, the stock ledger shall be the only evidence as to the stockholders
entitled to examine the list of stockholders required by this <U>Section&nbsp;12</U> or to vote in person or by proxy at any meeting
of the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;13.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Action
Without Meeting</B></FONT>. Unless otherwise provided in the Certificate of Incorporation, no action shall be taken by the stockholders
of the corporation except at an annual or a special meeting of the stockholders called in accordance with these Bylaws, and no action
of the stockholders of the corporation may be taken by consent or electronic transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;14.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Organization</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>At
every meeting of stockholders, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed or is absent, the
Chief Executive Officer, or if no Chief Executive Officer is then serving or is absent, the President, or, if the President is absent,
a chairperson of the meeting chosen by a majority in interest of the stockholders entitled to vote, present in person or by proxy duly
authorized, shall act as chairperson. The Chairperson of the Board may appoint the Chief Executive Officer as chairperson of the meeting.
The Secretary, or, in the Secretary&rsquo;s absence, an Assistant Secretary or other officer or other person directed to do so by the
Chairperson of the meeting, shall act as secretary of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
Board of Directors of the corporation shall be entitled to make such rules&nbsp;or regulations for the conduct of meetings of stockholders
as it shall deem necessary, appropriate or convenient. Subject to such rules&nbsp;and regulations of the Board of Directors, if any,
the chairperson of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such
acts as, in the judgment of such chairperson, are necessary, appropriate or convenient for the proper conduct of the meeting, including,
without limitation, establishing an agenda or order of business for the meeting, rules&nbsp;and procedures for maintaining order at the
meeting and the safety of those present, limitations on attendance at or participation in such meeting to stockholders of record of the
corporation and their duly authorized and constituted proxies and such other persons as the chairperson shall permit, restrictions on
entry to the meeting after the time fixed for the commencement thereof, limitations on the time allotted to questions or comments by
participants and regulation of the opening and closing of the polls for balloting on matters which are to be voted on by ballot. The
date and time of the opening and closing of the polls for each matter upon which the stockholders will vote at the meeting shall be announced
at the meeting. Unless and to the extent determined by the Board of Directors or the chairperson of the meeting, meetings of stockholders
shall not be required to be held in accordance with rules&nbsp;of parliamentary procedure.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>In
advance of any meeting of the stockholders, the Board of Directors, by resolution, the Chairperson of the Board of Directors or the Chief
Executive Officer shall appoint one or more inspectors to act at the meeting and make a written report thereof. One or more other persons
may be designated as alternate inspectors to replace any inspector who fails to act. If no inspector or alternate is able to act at a
meeting of the stockholders, the chairperson of the meeting shall appoint one or more inspectors to act at the meeting. Unless otherwise
required by applicable law, inspectors may be officers, employees or agents of the corporation. Each inspector, before entering upon
the discharge of the duties of inspector, shall take and sign an oath faithfully to execute the duties of inspector with strict impartiality
and according to the best of such inspector's ability. The inspector shall have the duties prescribed by law and shall take charge of
the polls and, when the vote is completed, shall execute and deliver to the corporation a certificate of the result of the vote taken
and of such other facts as may be required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV<FONT STYLE="text-transform: uppercase"><U><BR>
Directors</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;15.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Number</B></FONT>.
The authorized number of directors of the corporation shall be fixed in accordance with the Certificate of Incorporation. Directors need
not be stockholders unless so required by the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;16.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Powers</B></FONT>.
The business and affairs of the corporation shall be managed by or under the direction of the Board of Directors, except as may be otherwise
provided by law or by the Certificate of Incorporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;17.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Term
of Directors</B></FONT>. Subject to the rights of the holders of any series of preferred stock to elect additional directors under specified
circumstances, directors shall be elected at each annual meeting of stockholders to serve until the next annual meeting of stockholders.
Each director shall serve until such director&rsquo;s successor is duly elected and qualified or until such director&rsquo;s earlier
death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any
incumbent director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section&nbsp;18.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-variant: small-caps">Vacancies</FONT>.
</B>Unless otherwise provided in the Certificate of Incorporation, and subject to the rights of the holders of any series of preferred
stock or as otherwise provided by applicable law, any vacancies on the Board of Directors resulting from death, resignation, disqualification,
removal or other causes and any newly created directorships resulting from any increase in the number of directors shall, unless the
Board of Directors determines by resolution that any such vacancies or newly created directorships shall be filled by stockholders, be
filled only by the affirmative vote of a majority of the directors then in office, even though less than a quorum of the Board of Directors,
or by a sole remaining director, and not by the stockholders, <I>provided, however</I>, that whenever the holders of any class or classes
of stock or series thereof are entitled to elect one or more directors by the provisions of the Certificate of Incorporation, vacancies
and newly created directorships of such class or classes or series shall, unless the Board of Directors determines by resolution that
any such vacancies or newly created directorships shall be filled by stockholders, be filled by a majority of the directors elected by
such class or classes or series thereof then in office, or by a sole remaining director so elected, and not by the stockholders. Any
director elected in accordance with the preceding sentence shall hold office for the remainder of the full term of the director for which
the vacancy was created or occurred and until such director&rsquo;s successor shall have been elected and qualified. A vacancy in the
Board of Directors shall be deemed to exist under this Bylaw in the case of the death, removal or resignation of any director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;19.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Resignation</B></FONT>.
Any director may resign at any time by delivering notice in writing or by electronic transmission to the Secretary of the corporation,
such resignation to specify whether it will be effective at a particular time. If no such specification is made, the Secretary, in the
Secretary&rsquo;s discretion, may either (a)&nbsp;require confirmation from the director prior to deeming the resignation effective,
in which case the resignation will be deemed effective upon receipt of such confirmation, or (b)&nbsp;deem the resignation effective
at the time of delivery of the resignation to the Secretary of the corporation. A verbal resignation shall not be deemed effective until
confirmed by the director in writing or by electronic transmission to the Secretary of the corporation. When one or more directors shall
resign from the Board of Directors, effective at a future date, a majority of the directors then in office, including those who have
so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or resignations
shall become effective, and each director so chosen shall hold office for the unexpired portion of the term of the director whose place
shall be vacated and until such director&rsquo;s successor shall have been duly elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;20.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Removal</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Subject
to the rights of any series of preferred stock to elect additional directors under specified circumstances, neither the Board of Directors
nor any individual director may be removed without cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Subject
to any limitations imposed by applicable law, any individual director or directors may be removed from office with cause by the affirmative
vote of the holders of at least sixty-six and two-thirds percent (66 2/3%) of the voting power of all then outstanding shares of capital
stock of the corporation entitled to vote generally at an election of directors, voting together as a single class.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;21.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Meetings</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Regular
Meetings.</B> Unless otherwise restricted by the Certificate of Incorporation, regular meetings of the Board of Directors may be held
at any time or date and at any place within or outside of the State of Delaware which has been designated by the Board of Directors,
with notice thereof given to all directors, either orally or in writing, by telephone, including a voice-messaging system or other system
designed to record and communicate messages, facsimile, telegraph or telex, or by electronic mail or other electronic means. No further
notice shall be required for regular meetings of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Special
Meetings. </B>Unless otherwise restricted by the Certificate of Incorporation, special meetings of the Board of Directors may be held
at any time and place within or outside of the State of Delaware whenever called by the Chairperson of the Board, the Chief Executive
Officer or a majority of the total number of authorized directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Meetings
by Electronic Communications Equipment. </B>Any member of the Board of Directors, or of any committee thereof, may participate in a meeting
by means of conference telephone or other communications equipment by means of which all persons participating in the meeting can hear
each other, and participation in a meeting by such means shall constitute presence in person at such meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notice
of Special Meetings. </B>Notice of the time and place of all special meetings of the Board of Directors shall be orally or in writing,
by telephone, including a voice messaging system or other system or technology designed to record and communicate messages, facsimile,
telegraph or telex, or by electronic mail or other electronic means, during normal business hours, at least twenty-four (24) hours before
the date and time of the meeting. If notice is sent by U.S. mail, it shall be sent by first class mail, postage prepaid, at least three
(3)&nbsp;days before the date of the meeting. Notice of any meeting may be waived in writing, or by electronic transmission, at any time
before or after the meeting and will be waived by any director by attendance thereat, except when the director attends the meeting for
the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the meeting is not lawfully
called or convened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Waiver
of Notice. </B>The transaction of all business at any meeting of the Board of Directors, or any committee thereof, however called or
noticed, or wherever held, shall be as valid as though it had been transacted at a meeting duly held after regular call and notice, if
a quorum be present and if, either before or after the meeting, each of the directors not present who did not receive notice shall sign
a written waiver of notice or shall waive notice by electronic transmission. All such waivers shall be filed with the corporate records
or made a part of the minutes of the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;22.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Quorum
and Voting</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Unless
the Certificate of Incorporation requires a greater number, and except with respect to questions related to indemnification arising under
<U>Section&nbsp;44</U> for which a quorum shall be one-third of the exact number of directors fixed from time to time, a quorum of the
Board of Directors shall consist of a majority of the exact number of directors fixed from time to time by the Board of Directors in
accordance with the Certificate of Incorporation; <I>provided, however,</I> at any meeting whether a quorum be present or otherwise,
a majority of the directors present may adjourn from time to time until the time fixed for the next regular meeting of the Board of Directors,
without notice other than by announcement at the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>At
each meeting of the Board of Directors at which a quorum is present, all questions and business shall be determined by the affirmative
vote of a majority of the directors present, unless a different vote be required by law, the Certificate of Incorporation or these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;23.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Action
Without Meeting</B></FONT>. Unless otherwise restricted by the Certificate of Incorporation or these Bylaws, any action required or permitted
to be taken at any meeting of the Board of Directors or of any committee thereof may be taken without a meeting, if all members of the
Board of Directors or committee, as the case may be, consent thereto in writing or by electronic transmission, and such writing or writings
or transmission or transmissions are filed with the minutes of proceedings of the Board of Directors or committee. Such filing shall
be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic
form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;24.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Fees
and Compensation</B></FONT><B>.</B> Directors shall be entitled to such compensation for their services as may be approved by the Board
of Directors, including, if so approved, by resolution of the Board of Directors, a fixed sum and expenses of attendance, if any, for
attendance at each regular or special meeting of the Board of Directors and at any meeting of a committee of the Board of Directors.
Nothing herein contained shall be construed to preclude any director from serving the corporation in any other capacity as an officer,
agent, employee, or otherwise and receiving compensation therefor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;25.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Committees</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Executive
Committee.</B> The Board of Directors may appoint an Executive Committee to consist of one (1)&nbsp;or more members of the Board of Directors.
The Executive Committee, to the extent permitted by law and provided in the resolution of the Board of Directors shall have and may exercise
all the powers and authority of the Board of Directors in the management of the business and affairs of the corporation, and may authorize
the seal of the corporation to be affixed to all papers which may require it; but no such committee shall have the power or authority
in reference to (i)&nbsp;approving or adopting, or recommending to the stockholders, any action or matter (other than the election or
removal of directors) expressly required by the DGCL to be submitted to stockholders for approval, or (ii)&nbsp;adopting, amending or
repealing any Bylaw of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Other
Committees.</B> The Board of Directors may, from time to time, appoint such other committees as may be permitted by law. Such other committees
appointed by the Board of Directors shall consist of one (1)&nbsp;or more members of the Board of Directors and shall have such powers
and perform such duties as may be prescribed by the resolution or resolutions creating such committees, but in no event shall any such
committee have the powers denied to the Executive Committee in these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Term.</B>
The Board of Directors, subject to any requirements of any outstanding series of preferred stock and the provisions of subsections (a)&nbsp;or
(b)&nbsp;of this <U>Section&nbsp;25</U>, may at any time increase or decrease the number of members of a committee or terminate the existence
of a committee. The membership of a committee member shall terminate on the date of such committee member&rsquo;s death or voluntary
resignation from the committee or from the Board of Directors. The Board of Directors may at any time for any reason remove any individual
committee member and the Board of Directors may fill any committee vacancy created by death, resignation, removal or increase in the
number of members of the committee. The Board of Directors may designate one or more directors as alternate members of any committee,
who may replace any absent or disqualified member at any meeting of the committee, and, in addition, in the absence or disqualification
of any member of a committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such
committee member or members constitute a quorum, may unanimously appoint another member of the Board of Directors to act at the meeting
in the place of any such absent or disqualified member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Meetings.</B>
Unless the Board of Directors shall otherwise provide, regular meetings of the Executive Committee or any other committee appointed pursuant
to this <U>Section&nbsp;25</U> shall be held at such times and places as are determined by the Board of Directors, or by any such committee,
and when notice thereof has been given to each member of such committee, no further notice of such regular meetings need be given thereafter.
Special meetings of any such committee may be held at any place which has been determined from time to time by such committee, and may
be called by any director who is a member of such committee, upon notice to the members of such committee of the time and place of such
special meeting given in the manner provided for the giving of notice to members of the Board of Directors of the time and place of special
meetings of the Board of Directors. Notice of any special meeting of any committee may be waived in writing or by electronic transmission
at any time before or after the meeting and will be waived by any director by attendance thereat, except when the director attends such
special meeting for the express purpose of objecting, at the beginning of the meeting, to the transaction of any business because the
meeting is not lawfully called or convened. Unless otherwise provided by the Board of Directors in the resolutions authorizing the creation
of the committee, a majority of the authorized number of members of any such committee shall constitute a quorum for the transaction
of business, and the act of a majority of those present at any meeting at which a quorum is present shall be the act of such committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;26.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Chairperson of the Board of Directors and Lead Independent Director</B></FONT><B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
Chairperson of the Board of Directors, if appointed and when present, shall preside at all meetings of the stockholders and the Board
of Directors. The Chairperson of the Board of Directors shall perform other duties commonly incident to the office and shall also perform
such other duties and have such other powers, as the Board of Directors shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
Chairperson of the Board of Directors, or if the Chairperson is not an independent director, one of the independent directors, may be
designated by the Board of Directors as lead independent director to serve until replaced by the Board of Directors (&ldquo;<B><I>Lead
Independent Director</I></B>&rdquo;). The Lead Independent Director will: with the Chairperson of the Board of Directors and the Chief
Executive Officer, establish the agenda for Board meetings and serve as chairperson of Board of Directors meetings in the absence of
the Chairperson of the Board of Directors; establish the agenda for meetings of the independent directors; coordinate with the committee
chairs regarding meeting agendas and informational requirements; preside over meetings of the independent directors; preside over any
portions of meetings of the Board of Directors at which the evaluation or compensation of the Chief Executive Officer is presented or
discussed; preside over any portions of meetings of the Board of Directors at which the performance of the Board of Directors is presented
or discussed; and perform such other duties as may be established or delegated by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;27.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Organization</B></FONT>.
At every meeting of the directors, the Chairperson of the Board of Directors, or, if a Chairperson has not been appointed or is absent,
the Lead Independent Director, or if the Lead Independent Director has not been appointed or is absent, the Chief Executive Officer (if
a director), or, if a Chief Executive Officer is absent, the President (if a director), or if the President is absent, the most senior
Vice President (if a director), or, in the absence of any such person, a chairperson of the meeting chosen by a majority of the directors
present, shall preside over the meeting. The Secretary of the corporation, or in the Secretary&rsquo;s absence, any Assistant Secretary
or other officer, director or other person directed to do so by the person presiding over the meeting, shall act as secretary of the
meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V<FONT STYLE="text-transform: uppercase"><U><BR>
Officers</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;28.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Officers
Designated</B></FONT><B>. </B>The officers of the corporation shall include, if and when designated by the Board of Directors, the Chief
Executive Officer, the President, one or more Vice Presidents, the Secretary, the Chief Financial Officer and the Treasurer. The Board
of Directors may also appoint one or more Assistant Secretaries and Assistant Treasurers and such other officers and agents with such
powers and duties as it shall deem necessary. The Board of Directors may assign such additional titles to one or more of the officers
as it shall deem appropriate. Any one person may hold any number of offices of the corporation at any one time unless specifically prohibited
therefrom by law. The salaries and other compensation of the officers of the corporation shall be fixed by or in the manner designated
by the Board of Directors or a committee thereof to which the Board of Directors has delegated such responsibility. The election of an
officer shall not of itself create any contract rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;29.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Tenure
and Duties of Officers</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>General.</B>
All officers shall hold office at the pleasure of the Board of Directors and until their successors shall have been duly elected and
qualified, unless sooner removed. Any officer elected or appointed by the Board of Directors may be removed at any time by the Board
of Directors. If the office of any officer becomes vacant for any reason, the vacancy may be filled by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Chief Executive Officer.</B> The Chief Executive Officer shall preside at all meetings of the stockholders and at all meetings of
the Board of Directors (if a director), unless the Chairperson of the Board of Directors or the Lead Independent Director has been appointed
and is present. Unless an officer has been appointed Chief Executive Officer of the corporation, the President shall be the chief executive
officer of the corporation. To the extent that a Chief Executive Officer has been appointed and no President has been appointed, all
references in these Bylaws to the President shall be deemed references to the Chief Executive Officer. The Chief Executive Officer shall
(i)&nbsp;subject to the oversight and control of the Board of Directors, have general supervision, direction and control of the business
and officers of the corporation and (ii)&nbsp;perform other duties commonly incident to the office and shall also perform such other
duties and have such other powers, as the Board of Directors shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of President.</B> The President shall preside at all meetings of the stockholders and at all meetings of the Board of Directors (if a
director), unless the Chairperson of the Board of Directors, the Lead Independent Director or the Chief Executive Officer has been appointed
and is present. Unless another officer has been appointed Chief Executive Officer of the corporation, the President shall be the Chief
Executive Officer of the corporation and shall, subject to the oversight and control of the Board of Directors, have general supervision,
direction and control of the business and officers of the corporation. The President shall perform other duties commonly incident to
the office and shall also perform such other duties and have such other powers, as the Board of Directors (or the Chief Executive Officer,
if the Chief Executive Officer and President are not the same person and the Board of Directors has delegated the designation of the
President&rsquo;s duties to the Chief Executive Officer) shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Vice Presidents.</B> The Vice Presidents may assume and perform the duties of the President in the absence or disability of the President
or whenever the office of President is vacant (unless the duties of the President are being filled by the Chief Executive Officer). The
Vice Presidents shall perform other duties commonly incident to their office and shall also perform such other duties and have such other
powers as the Board of Directors or the Chief Executive Officer, or, if the Chief Executive Officer has not been appointed or is absent,
the President shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Secretary.</B> The Secretary shall attend all meetings of the stockholders and of the Board of Directors and shall record all acts
and proceedings thereof in the minute book of the corporation. The Secretary shall give notice in conformity with these Bylaws of all
meetings of the stockholders and of all meetings of the Board of Directors and any committee thereof requiring notice. The Secretary
shall perform all other duties provided for in these Bylaws and other duties commonly incident to the office and shall also perform such
other duties and have such other powers, as the Board of Directors shall designate from time to time. The Chief Executive Officer, or
if no Chief Executive Officer is then serving, the President may direct any Assistant Secretary or other officer to assume and perform
the duties of the Secretary in the absence or disability of the Secretary, and each Assistant Secretary shall perform other duties commonly
incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the Chief Executive
Officer, or if no Chief Executive Officer is then serving, the President shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Chief Financial Officer.</B> The Chief Financial Officer shall keep or cause to be kept the books of account of the corporation in
a thorough and proper manner and shall render statements of the financial affairs of the corporation in such form and as often as required
by the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President. The Chief
Financial Officer, subject to the order of the Board of Directors, shall have the custody of all funds and securities of the corporation.
The Chief Financial Officer shall perform other duties commonly incident to the office and shall also perform such other duties and have
such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President
shall designate from time to time. To the extent that a Chief Financial Officer has been appointed and no Treasurer has been appointed,
all references in these Bylaws to the Treasurer shall be deemed references to the Chief Financial Officer. The President may direct the
Treasurer, if any, or any Assistant Treasurer, or the controller or any assistant controller to assume and perform the duties of the
Chief Financial Officer in the absence or disability of the Chief Financial Officer, and each Treasurer and Assistant Treasurer and each
controller and assistant controller shall perform other duties commonly incident to the office and shall also perform such other duties
and have such other powers as the Board of Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving,
the President shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Duties
of Treasurer.</B> Unless another officer has been appointed Chief Financial Officer of the corporation, the Treasurer shall be the chief
financial officer of the corporation and shall keep or cause to be kept the books of account of the corporation in a thorough and proper
manner and shall render statements of the financial affairs of the corporation in such form and as often as required by the Board of
Directors or the Chief Executive Officer, or if no Chief Executive Officer is then serving, the President, and, subject to the order
of the Board of Directors, shall have the custody of all funds and securities of the corporation. The Treasurer shall perform other duties
commonly incident to the office and shall also perform such other duties and have such other powers as the Board of Directors or the
Chief Executive Officer, or if no Chief Executive Officer is then serving, the President and Chief Financial Officer (if not Treasurer)
shall designate from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;30.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Delegation
of Authority</B></FONT>. The Board of Directors may from time to time delegate the powers or duties of any officer to any other officer
or agent, notwithstanding any provision hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;31.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Resignations</B></FONT><B>.</B>
Any officer may resign at any time by giving notice in writing or by electronic transmission to the Board of Directors or to the Chief
Executive Officer, or if no Chief Executive Officer is then serving, the President or to the Secretary. Any such resignation shall be
effective when received by the person or persons to whom such notice is given, unless a later time is specified therein, in which event
the resignation shall become effective at such later time. Unless otherwise specified in such notice, the acceptance of any such resignation
shall not be necessary to make it effective. Any resignation shall be without prejudice to the rights, if any, of the corporation under
any contract with the resigning officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;32.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Removal</B></FONT><B>.</B>
Any officer may be removed from office at any time, either with or without cause, by the affirmative vote of a majority of the directors
in office at the time, or by the unanimous written consent of the directors in office at the time, or by any committee or by the Chief
Executive Officer or by other superior officers upon whom such power of removal may have been conferred by the Board of Directors, but
such removal shall be without prejudice to the contract rights, if any, of the person so removed. Any officer or agent elected or appointed
by the President may be removed by the President whenever in the President&rsquo;s judgment the best interests of the corporation would
be served thereby, but such removal shall be without prejudice to the contract rights, if any, of the person so removed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI<FONT STYLE="text-transform: uppercase"><U><BR>
Execution Of Corporate Instruments And Voting Of Securities Owned By The Corporation</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;33.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Execution
of Corporate Instruments</B></FONT>. The Board of Directors may, in its discretion, determine the method and designate the signatory
officer or officers, or other person or persons, to execute on behalf of the corporation any corporate instrument or document, or to
sign on behalf of the corporation the corporate name without limitation, or to enter into contracts on behalf of the corporation, except
where otherwise provided by law or these Bylaws, and such execution or signature shall be binding upon the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All checks and drafts drawn on banks or other
depositaries on funds to the credit of the corporation or in special accounts of the corporation shall be signed by such person or persons
as the Board of Directors shall authorize so to do.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless authorized or ratified by the Board of
Directors or within the agency power of an officer, no officer, agent or employee shall have any power or authority to bind the corporation
by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;34.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Voting
of Securities Owned by the Corporation</B></FONT>. All stock and other securities of other corporations owned or held by the corporation
for itself, or for other parties in any capacity, shall be voted, and all proxies with respect thereto shall be executed, by the person
authorized so to do by resolution of the Board of Directors, or, in the absence of such authorization, by the Chairperson of the Board
of Directors, the Chief Executive Officer, the President, or any Vice President.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VII<FONT STYLE="text-transform: uppercase"><U><BR>
Shares Of Stock</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;35.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Form&nbsp;and
Execution of Certificates</B></FONT>. The shares of the corporation shall be represented by certificates, or shall be uncertificated
shares that may be evidenced by a book-entry system maintained by the registrar of such stock if so provided by resolution or resolutions
of the Board of Directors. Certificates for the shares of stock of the corporation, if any, shall be in such form as is consistent with
the Certificate of Incorporation and applicable law. Every holder of stock in the corporation represented by certificate shall be entitled
to have a certificate signed by or in the name of the corporation by the Chairperson of the Board of Directors, or the President or any
Vice President and by the Treasurer or Assistant Treasurer or the Secretary or Assistant Secretary, certifying the number of shares owned
by such holder in the corporation. Any or all of the signatures on the certificate may be facsimile or other electronic means. In case
any officer, transfer agent, or registrar who has signed or whose facsimiles or other electronic signature has been placed upon a certificate
shall have ceased to be such officer, transfer agent, or registrar before such certificate is issued, it may be issued with the same
effect as if he or she were such officer, transfer agent, or registrar at the date of issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;36.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Lost
Certificates</B></FONT>. A new certificate or certificates shall be issued in place of any certificate or certificates theretofore issued
by the corporation alleged to have been lost, stolen, or destroyed, upon the making of an affidavit of that fact by the person claiming
the certificate of stock to be lost, stolen, or destroyed. The corporation may require, as a condition precedent to the issuance of a
new certificate, certificates or uncertificated shares, the owner of such lost, stolen, or destroyed certificate or certificates, or
the owner&rsquo;s legal representative, to agree to indemnify the corporation in such manner as it shall require or to give the corporation
a surety bond in such form and amount as it may direct as indemnity against any claim that may be made against the corporation with respect
to the certificate alleged to have been lost, stolen, or destroyed or the issuance of such new certificate, certificates or uncertificated
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;37.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Transfers</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>Transfers
of record of shares of stock of the corporation shall be made in the manner prescribed by law and in these Bylaws. Transfers of stock
shall be made on the books administered by or on behalf of the corporation only by the direction of the registered holder thereof, or
by such holder&rsquo;s attorney duly authorized in writing, and, in the case of stock represented by certificate, upon the surrender
to the corporation of the certificate or certificates for such shares, which shall be cancelled before a new certificate or uncertificated
shares shall be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes of stock
of the corporation to restrict the transfer of shares of stock of the corporation of any one or more classes owned by such stockholders
in any manner not prohibited by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;38.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Fixing
Record Dates</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>In
order that the corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any adjournment
thereof, the Board of Directors may fix a record date, which record date shall not precede the date upon which the resolution fixing
the record date is adopted by the Board of Directors, and which record date shall, subject to applicable law, not be more than sixty
(60) nor less than ten (10)&nbsp;days before the date of such meeting, subject to the provisions of <U>Section&nbsp;5</U>. If no record
date is fixed by the Board of Directors, the record date for determining stockholders entitled to notice of or to vote at a meeting of
stockholders shall be at the close of business on the day next preceding the day on which notice is given, or if notice is waived, at
the close of business on the day next preceding the day on which the meeting is held. A determination of stockholders of record entitled
to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; <I>provided, however,</I> that the
Board of Directors may fix a new record date for the adjourned meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>In
order that the corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment
of any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of stock, or for the
purpose of any other lawful action, the Board of Directors may fix, in advance, a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60) days prior
to such action. If no record date is fixed, the record date for determining stockholders for any such purpose shall be at the close of
business on the day on which the Board of Directors adopts the resolution relating thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;39.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Registered
Stockholders</B></FONT>. The corporation shall be entitled to recognize the exclusive right of a person registered on its books as the
owner of shares to receive dividends, and to vote as such owner, and shall not be bound to recognize any equitable or other claim to
or interest in such share or shares on the part of any other person whether or not it shall have express or other notice thereof, except
as otherwise provided by the DGCL.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VIII<FONT STYLE="text-transform: uppercase"><U><BR>
Other Securities Of The Corporation</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;40.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Execution
of Other Securities</B></FONT><B>. </B>All bonds, debentures and other corporate securities of the corporation, other than stock certificates
(covered in <U>Section&nbsp;35</U>), may be signed by the Chairperson of the Board of Directors, the Chief Executive Officer, the President
or any Vice President, or such other person as may be authorized by the Board of Directors; <I>provided, however,</I> that where any
such bond, debenture or other corporate security shall be authenticated by the manual signature, or where permissible facsimile signature,
of a trustee under an indenture pursuant to which such bond, debenture or other corporate security shall be issued, the signatures of
the persons signing such bond, debenture or other corporate security may be the imprinted facsimile of the signatures of such persons.
Interest coupons appertaining to any such bond, debenture or other corporate security, authenticated by a trustee as aforesaid, shall
be signed by the Treasurer or an Assistant Treasurer of the corporation or such other person as may be authorized by the Board of Directors,
or bear imprinted thereon the facsimile signature of such person. In case any officer who shall have signed or attested any bond, debenture
or other corporate security, or whose facsimile signature shall appear thereon or on any such interest coupon, shall have ceased to be
such officer before the bond, debenture or other corporate security so signed or attested shall have been delivered, such bond, debenture
or other corporate security nevertheless may be adopted by the corporation and issued and delivered as though the person who signed the
same or whose facsimile signature shall have been used thereon had not ceased to be such officer of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IX<FONT STYLE="text-transform: uppercase"><U><BR>
Dividends</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;41.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Declaration
of Dividends</B></FONT>. Dividends upon the capital stock of the corporation, subject to the provisions of the Certificate of Incorporation
and applicable law, if any, may be declared by the Board of Directors pursuant to law at any regular or special meeting. Dividends may
be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation and applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;42.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Dividend
Reserve</B></FONT>. Before payment of any dividend, there may be set aside out of any funds of the corporation available for dividends
such sum or sums as the Board of Directors from time to time, in their absolute discretion, think proper as a reserve or reserves to
meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the corporation, or for such other purpose
as the Board of Directors shall think conducive to the interests of the corporation, and the Board of Directors may modify or abolish
any such reserve in the manner in which it was created.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;X<FONT STYLE="text-transform: uppercase"><U><BR>
Fiscal Year</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;43.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Fiscal
Year</B></FONT>. The fiscal year of the corporation shall be fixed by resolution of the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XI<FONT STYLE="text-transform: uppercase"><U><BR>
Indemnification</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;44.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Indemnification
of Directors, Executive Officers, Other Officers, Employees and Other Agents</B></FONT><B>.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Directors
and Executive Officers. </B>The corporation shall indemnify its directors and executive officers (for the purposes of this Article&nbsp;XI,
 &ldquo;<B><I>executive officers</I></B>&rdquo; shall have the meaning defined in Rule&nbsp;3b-7 promulgated under the 1934 Act) to the
extent not prohibited by the DGCL or any other applicable law; <I>provided, however,</I> that the corporation may modify the extent of
such indemnification by individual contracts with its directors and executive officers; and, <I>provided, further,</I> that the corporation
shall not be required to indemnify any director or executive officer in connection with any proceeding (or part thereof) initiated by
such person unless (i)&nbsp;such indemnification is expressly required to be made by law, (ii)&nbsp;the proceeding was authorized by
the Board of Directors of the corporation, (iii)&nbsp;such indemnification is provided by the corporation, in its sole discretion, pursuant
to the powers vested in the corporation under the DGCL or any other applicable law or (iv)&nbsp;such indemnification is required to be
made under subsection (d)&nbsp;of this <U>Section&nbsp;44</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Other
Officers, Employees and Other Agents.</B> The corporation shall have the power to indemnify (including the power to advance expenses
in a manner consistent with subsection (c)) its other officers, employees and other agents as set forth in the DGCL or any other applicable
law. The Board of Directors shall have the power to delegate the determination of whether indemnification shall be given to any such
person except executive officers to such officers or other persons as the Board of Directors shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Expenses.</B>
The corporation shall advance to any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that such person is or was
a director or executive officer, of the corporation, or is or was serving at the request of the corporation as a director or executive
officer of another corporation, partnership, joint venture, trust or other enterprise, prior to the final disposition of the proceeding,
promptly following request therefor, all expenses actually and reasonably incurred by any director or executive officer in connection
with such proceeding provided, however, that if the DGCL requires, an advancement of expenses incurred by a director or executive officer
in such person&rsquo;s capacity as a director or executive officer (and not in any other capacity in which service was or is rendered
by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made only upon delivery to the corporation
of an undertaking (hereinafter an &ldquo;<B><I>undertaking</I></B>&rdquo;), by or on behalf of such indemnitee, to repay all amounts
so advanced if it shall ultimately be determined by final judicial decision from which there is no further right to appeal (hereinafter
a &ldquo;<B><I>final adjudication</I></B>&rdquo;) that such indemnitee is not entitled to be indemnified for such expenses under this
<U>Section&nbsp;44</U> or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, unless otherwise
determined pursuant to paragraph (e)&nbsp;of this <U>Section&nbsp;44</U>, no advance shall be made by the corporation to an executive
officer of the corporation (except by reason of the fact that such executive officer is or was a director of the corporation in which
event this paragraph shall not apply) in any action, suit or proceeding, whether civil, criminal, administrative or investigative, if
a determination is reasonably and promptly made (i)&nbsp;by a majority vote of directors who were not parties to the proceeding, even
if not a quorum, or (ii)&nbsp;by a committee of such directors designated by a majority vote of such directors, even though less than
a quorum, or (iii)&nbsp;if there are no such directors, or such directors so direct, by independent legal counsel in a written opinion,
that the facts known to the decision-making party at the time such determination is made demonstrate clearly and convincingly that such
person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Enforcement.
</B>Without the necessity of entering into an express contract, all rights to indemnification and advances to directors and executive
officers under this <U>Section&nbsp;44</U> shall be deemed to be contractual rights and be effective to the same extent and as if provided
for in a contract between the corporation and the director or executive officer. Any right to indemnification or advances granted by
this <U>Section&nbsp;44</U> to a director or executive officer shall be enforceable by or on behalf of the person holding such right
in any court of competent jurisdiction if (i)&nbsp;the claim for indemnification or advances is denied, in whole or in part, or (ii)&nbsp;no
disposition of such claim is made within ninety (90) days of request therefor. To the extent permitted by law, the claimant in such enforcement
action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting the claim. In connection with
any claim for indemnification, the corporation shall be entitled to raise as a defense to any such action that the claimant has not met
the standards of conduct that make it permissible under the DGCL or any other applicable law for the corporation to indemnify the claimant
for the amount claimed. In connection with any claim by an executive officer of the corporation (except in any action, suit or proceeding,
whether civil, criminal, administrative or investigative, by reason of the fact that such executive officer is or was a director of the
corporation) for advances, the corporation shall be entitled to raise a defense as to any such action clear and convincing evidence that
such person acted in bad faith or in a manner that such person did not believe to be in or not opposed to the best interests of the corporation,
or with respect to any criminal action or proceeding that such person acted without reasonable cause to believe that such person&rsquo;s
conduct was lawful. Neither the failure of the corporation (including its Board of Directors, independent legal counsel or its stockholders)
to have made a determination prior to the commencement of such action that indemnification of the claimant is proper in the circumstances
because the claimant has met the applicable standard of conduct set forth in the DGCL or any other applicable law, nor an actual determination
by the corporation (including its Board of Directors, independent legal counsel or its stockholders) that the claimant has not met such
applicable standard of conduct, shall be a defense to the action or create a presumption that claimant has not met the applicable standard
of conduct. In any suit brought by a director or executive officer to enforce a right to indemnification or to an advancement of expenses
hereunder, the burden of proving that the director or executive officer is not entitled to be indemnified, or to such advancement of
expenses, under this <U>Section&nbsp;44</U> or otherwise shall be on the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Non-Exclusivity
of Rights. </B>The rights conferred on any person by this Bylaw shall not be exclusive of any other right which such person may have
or hereafter acquire under any applicable law, provision of the Certificate of Incorporation, Bylaws, agreement, vote of stockholders
or disinterested directors or otherwise, both as to action in such person&rsquo;s official capacity and as to action in another capacity
while holding office. The corporation is specifically authorized to enter into individual contracts with any or all of its directors,
officers, employees or agents respecting indemnification and advances, to the fullest extent not prohibited by the DGCL, or by any other
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Survival
of Rights. </B>The rights conferred on any person by this Bylaw shall continue as to a person who has ceased to be a director or executive
officer or officer, employee or other agent and shall inure to the benefit of the heirs, executors and administrators of such a person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(g)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Insurance.
</B>To the fullest extent permitted by the DGCL or any other applicable law, the corporation, upon approval by the Board of Directors,
may purchase insurance on behalf of any person required or permitted to be indemnified pursuant to this <U>Section&nbsp;44</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(h)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Amendments.
</B>Any repeal or modification of this <U>Section&nbsp;44</U> shall only be prospective and shall not affect the rights under this Bylaw
in effect at the time of the alleged occurrence of any action or omission to act that is the cause of any proceeding against any agent
of the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(i)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Saving
Clause. </B>If this Bylaw or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the corporation
shall nevertheless indemnify each director and executive officer to the full extent not prohibited by any applicable portion of this
<U>Section&nbsp;44</U> that shall not have been invalidated, or by any other applicable law. If this <U>Section&nbsp;44</U> shall be
invalid due to the application of the indemnification provisions of another jurisdiction, then the corporation shall indemnify each director
and executive officer to the full extent under any other applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(j)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Certain
Definitions. </B>For the purposes of this Bylaw, the following definitions shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(i)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
term &ldquo;<B><I>proceeding</I></B>&rdquo; shall be broadly construed and shall include, without limitation, the investigation, preparation,
prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending or completed action,
suit or proceeding, whether civil, criminal, administrative or investigative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(ii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
term &ldquo;<B><I>expenses</I></B>&rdquo; shall be broadly construed and shall include, without limitation, court costs, attorneys&rsquo;
fees, witness fees, fines, amounts paid in settlement or judgment and any other costs and expenses of any nature or kind incurred in
connection with any proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iii)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>The
term the &ldquo;<B><I>corporation</I></B>&rdquo; shall include, in addition to the resulting corporation, any constituent corporation
(including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would
have had power and authority to indemnify its directors, officers, and employees or agents, so that any person who is or was a director,
officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a
director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, shall stand in the
same position under the provisions of this <U>Section&nbsp;44</U> with respect to the resulting or surviving corporation as he or she
would have with respect to such constituent corporation if its separate existence had continued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(iv)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>References
to a &ldquo;<B><I>director</I></B>,&rdquo; &ldquo;<B><I>executive officer</I></B>,&rdquo; &ldquo;<B><I>officer</I></B>,&rdquo; &ldquo;<B><I>employee</I></B>,&rdquo;
or &ldquo;<B><I>agent</I></B>&rdquo; of the corporation shall include, without limitation, situations where such person is serving at
the request of the corporation as, respectively, a director, executive officer, officer, employee, trustee or agent of another corporation,
partnership, joint venture, trust or other enterprise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><B>(v)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT></B>References
to &ldquo;<B><I>other enterprise</I></B>&rdquo; shall include employee benefit plans; references to &ldquo;<B><I>fines</I></B>&rdquo;
shall include any excise taxes assessed on a person with respect to an employee benefit plan; and references to &ldquo;<B><I>serving
at the request of the corporation</I></B>&rdquo; shall include any service as a director, officer, employee or agent of the corporation
which imposes duties on, or involves services by, such director, officer, employee, or agent with respect to an employee benefit plan,
its participants, or beneficiaries; and a person who acted in good faith and in a manner such person reasonably believed to be in the
interest of the participants and beneficiaries of an employee benefit plan shall be deemed to have acted in a manner &ldquo;<B><I>not
opposed to the best interests of the corporation</I></B>&rdquo; as referred to in this <U>Section&nbsp;44</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XII<FONT STYLE="text-transform: uppercase"><U><BR>
Notices</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;45.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notices</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(a)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notice
to Stockholders. </B>Written notice to stockholders of stockholder meetings shall be given as provided in <U>Section&nbsp;7</U>. Without
limiting the manner by which notice may otherwise be given effectively to stockholders under any agreement or contract with such stockholder,
and except as otherwise required by law, written notice to stockholders for purposes other than stockholder meetings may be sent (a)&nbsp;by
mail, postage prepaid, addressed to such stockholder at such stockholder&rsquo;s address as it appears on the records of the corporation,
(b)&nbsp;by electronic transmission directed to such stockholder&rsquo;s electronic mail address as it appears on the record of the corporation
or (c)&nbsp;by any other method permitted by law (including, but not limited to, overnight courier service, facsimile or other means
of electronic transmission). Any notice shall be deemed to have been given (i)&nbsp;if mailed, when the notice is deposited in the United
States mail, postage prepaid, (ii)&nbsp;if delivered by courier service, the earlier of when the notice is received or left at such stockholder&rsquo;s
address or (iii)&nbsp;if given by electronic mail, when directed to such stockholder&rsquo;s electronic mail address unless such stockholder
has notified the corporation in writing or by electronic transmission of an objection to receiving notice by electronic mail or such
notice is prohibited by applicable law, the certificate of incorporation or these Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(b)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notice
to Directors. </B>Any notice required to be given to any director may be given by the method stated in subsection (a)&nbsp;or as otherwise
provided in these Bylaws, with notice other than one which is delivered personally to be sent to such address as such director shall
have filed in writing with the Secretary, or, in the absence of such filing, to the last known address of such director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(c)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Affidavit
of Mailing. </B>An affidavit of mailing, executed by a duly authorized and competent employee of the corporation or its transfer agent
appointed with respect to the class of stock affected, or other agent, specifying the name and address or the names and addresses of
the stockholder or stockholders, or director or directors, to whom any such notice or notices was or were given, and the time and method
of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(d)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Methods
of Notice. </B>It shall not be necessary that the same method of giving notice be employed in respect of all recipients of notice, but
one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in
respect of any other or others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(e)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notice
to Person With Whom Communication is Unlawful. </B>Whenever notice is required to be given, under any provision of law or of the Certificate
of Incorporation or Bylaws of the corporation, to any person with whom communication is unlawful, the giving of such notice to such person
shall not be required and there shall be no duty to apply to any governmental authority or agency for a license or permit to give such
notice to such person. Any action or meeting which shall be taken or held without notice to any such person with whom communication is
unlawful shall have the same force and effect as if such notice had been duly given. In the event that the action taken by the corporation
is such as to require the filing of a certificate under any provision of the DGCL, the certificate shall state, if such is the fact and
if notice is required, that notice was given to all persons entitled to receive notice except such persons with whom communication is
unlawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><B>(f)<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Notice
to Stockholders Sharing an Address. </B>Except as otherwise prohibited under the DGCL, any notice given under the provisions of the DGCL,
the Certificate of Incorporation or these Bylaws shall be effective if given by a single written notice to stockholders who share an
address if consented to by the stockholders at that address to whom such notice is given. Such consent shall have been deemed to have
been given if such stockholder fails to object in writing to the corporation within sixty (60) days of having been given notice by the
corporation of its intention to send the single notice. Any consent shall be revocable by the stockholder by written notice to the corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XIII<FONT STYLE="text-transform: uppercase"><U><BR>
Amendments</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;46.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Amendments</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the limitations set forth in <U>Section&nbsp;44(h)</U>&nbsp;or
the provisions of the Certificate of Incorporation, the Board of Directors is expressly empowered to adopt, amend or repeal these Bylaws
of the corporation. Any adoption, amendment or repeal of these Bylaws of the corporation by the Board of Directors shall require the
approval of a majority of the authorized number of directors present at the meeting of a Board of Directors at which a quorum is present.
The stockholders also shall have power to adopt, amend or repeal these Bylaws of the corporation; provided, however, that, in addition
to any vote of the holders of any class or series of stock of the corporation required by law or by the Certificate of Incorporation,
such action by stockholders shall require the affirmative vote of the holders of at least sixty-six and two-thirds percent (66-2/3%)
of the voting power of all of the then-outstanding shares of the capital stock of the corporation entitled to vote generally in the election
of directors, voting together as a single class. Any proposal by a stockholder to amend these Bylaws will also be subject to the provisions
of Article&nbsp;III.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;XIV<FONT STYLE="text-transform: uppercase"><U><BR>
FORUM FOR ADJUDICATION OF DISPUTES</U></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-variant: small-caps"><B>Section&nbsp;47.<FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Forum
for Adjudication of Disputes.</B></FONT> Unless the corporation consents in writing to the selection of an alternative forum, the Court
of Chancery of the State of Delaware (or, if and only if the Court of Chancery of the State of Delaware lacks subject matter jurisdiction,
any state court located within the State of Delaware or, if and only if all such state courts lack subject matter jurisdiction, the federal
district court for the District of Delaware) shall be the sole and exclusive forum for the following types of actions or proceedings:
(a)&nbsp;any derivative action or proceeding brought on behalf of the corporation, (b)&nbsp;any action asserting a claim of breach of
a fiduciary duty owed by any director, officer, employee or stockholder of the corporation to the corporation or the corporation&rsquo;s
stockholders, (c)&nbsp;any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation or
these Bylaws (as either may be amended or restated) or as to which the DGCL confers jurisdiction on the Court of Chancery of the State
of Delaware or (d)&nbsp;any action asserting a claim governed by the internal affairs doctrine, in all cases to the fullest extent permitted
by law and subject to the court&rsquo;s having personal jurisdiction over the indispensable parties named as defendants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any action the subject
matter of which is within the scope of this <U>Section&nbsp;47</U> is filed in a court other than a court located within the State of
Delaware (a <B><I>&ldquo;Foreign Action&rdquo;</I></B>) in the name of any stockholder, such stockholder shall be deemed to have consented
to: (i)&nbsp;the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action
brought in any such court to enforce this <U>Section&nbsp;47</U> (an <B><I>&ldquo;Enforcement Action&rdquo;</I></B>); and (ii)&nbsp;having
service of process made upon such stockholder in any such Enforcement Action by service upon such stockholder&rsquo;s counsel in the
Foreign Action as agent for such stockholder. This <U>Section&nbsp;47</U> shall not apply to actions brought to enforce a duty or liability
created by the 1934 Act or the Securities Act of 1933, as amended, or any claim for which the federal courts have exclusive jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any person or entity purchasing
or otherwise acquiring any interest in shares of capital stock of the corporation shall be deemed to have notice of and consented to
the provisions of this <U>Section&nbsp;47</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>tm2527115d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Preeminent SOL Treasury Company Helius (NASDAQ:HSDT)
Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>HSDT Solana Company's Mission is to maximize
SOL per share on one of the most commercially viable blockchains for consumer applications while delivering consistent on-chain yield
for investors</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>HSDT enters into agreement with the Solana
Foundation to establish its collaboration and commit to joint initiatives</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>This signifies HSDT&rsquo;s commitment to
building a long-lasting institution that accelerates the growth of Solana and being a powerful advocate for Solana's development alongside
the independent Solana Foundation and Solana Lab</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Newtown, PA, September 29, 2025 -- Helius Medical
Technologies, Inc. (Nasdaq: HSDT) (&ldquo;<U>HSDT</U>&rdquo; or the &ldquo;Company&rdquo;) announced that, following receipt of approval
from its Board of Directors, it has filed an amendment to its Certificate of Incorporation with the Delaware Secretary of State and amended
the Second Amended and Restated Bylaws to reflect a corporate name change from &ldquo;Helius Medical Technologies, Inc.&rdquo; to &ldquo;Solana
Company.&rdquo; The Company&rsquo;s ticker symbol for its Class A common stock, HSDT, will remain the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the Company and certain of its investors
entered into a non-binding letter of intent with the Solana Foundation (the &ldquo;Foundation&rdquo;), which sets forth the principal
terms of HSDT&rsquo;s commitment to abide by &ldquo;Solana By Design&rdquo; terms, which includes conducting all on-chain activity solely
on Solana (&ldquo;SOL&rdquo;), institutional partnerships referrals, and joint initiatives to highlight Solana capabilities (including
co-hosted events, institutional roundtables and participation at Solana Foundation events). HSDT will have the option, subject to certain
conditions, to purchase a certain amount of SOL tokens from the Foundation at a discount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is also continuing to execute on its
accumulation of SOL tokens as part of its digital asset treasury strategy. The Company still holds cash from its recent $500mm PIPE financing,
which the Company intends to use to further its digital asset treasury strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;DATs are providing access to the blockchain
market to a new kind of investor. Solana Company is well set up to be the preeminent SOL DAT by introducing Solana to a growing audience,&rdquo;
said Dan Morehead, Founder and Managing Partner of Pantera Capital and Strategic Advisor to HSDT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Solana Company is a name that signifies
HSDT&rsquo;s commitment to building a long-lasting institution that accelerates the growth of Solana. HSDT&rsquo;s Solana DAT will be
a powerful advocate for Solana's development,&rdquo;
said Cosmo Jiang, General Partner at Pantera Capital and Board Observer at HSDT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;HSDT&rsquo;s announcements today, including
a corporate name change and agreement with the Solana Foundation, showcase its long-term conviction in Solana. The clear long-term alignment
is a show of support and sign of strength for the Solana Company&rsquo;s mission,&rdquo; said Joseph Chee, Executive Chairman of HSDT
and Chairman of Summer Capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Solana has historically been the fastest growing
blockchain, leading the industry in transaction revenue and processing more than 3,500 transactions per second. The network is also the
most widely adopted, averaging about 3.7 million daily active wallets and surpassing 23 billion transactions year-to-date. SOL is financially
productive by design, offering a ~7% native staking yield, whereas assets like Bitcoin (BTC) are typically non-yield-bearing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About HSDT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Helius Medical Technologies, Inc. is a leading
neurotech company in the medical device field focused on neurologic deficits using orally applied technology platform that amplifies the
brain&rsquo;s ability to engage physiologic compensatory mechanisms and promote neuroplasticity, improving the lives of people dealing
with neurologic diseases. The Company&rsquo;s first commercial product is the Portable Neuromodulation Stimulator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has adopted a&nbsp;digital asset&nbsp;treasury
strategy focused on accumulating SOL, the native&nbsp;digital asset&nbsp;of the&nbsp;Solana&nbsp;blockchain, leveraging capital markets
raises that produce consistent on-chain yield generation. Helius Medical Technologies, Inc. will provide access to the&nbsp;Solana&nbsp;network.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif">This
press release contains statements that constitute &ldquo;forward-looking statements&rdquo; within the meaning of the U.S. federal securities
laws. Forward-looking statements are statements other than historical facts and include, without limitation, statements regarding the
potential for and amount of additional cash proceeds from warrant exercises, the anticipated use of proceeds from the announced Offering,&nbsp;</FONT><FONT STYLE="color: #242424">future
stockholder approvals,&nbsp;</FONT>future announcements and priorities, expectations regarding management,&nbsp;<FONT STYLE="color: #242424">corporate
governance,&nbsp;</FONT>market position, business strategies, future financial and operating performance, and other projections or statements
of plans and objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">These forward-looking
statements are based on current expectations, estimates, assumptions, and projections, and involve known and unknown risks, uncertainties,
and other factors&mdash;many of which are beyond the Company&rsquo;s control&mdash;that may cause actual results, performance, or achievements
to differ materially from those expressed or implied by such statements. Important factors that may affect actual results include, among
others, the Company&rsquo;s ability to execute its growth strategy; its ability to raise and deploy capital effectively; developments
in technology and the competitive landscape; the market performance of SOL; and other risks and uncertainties described under &ldquo;Risk
Factors&rdquo; in the Company&rsquo;s Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;25, 2025, and in other subsequent
filings with the SEC. These filings are available at&nbsp;<U>www.sec.gov.</U>&nbsp;The Company undertakes no obligation to update or revise
any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Twitter/X:&nbsp;</B></FONT>@HeliusHSDT&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #242424"><B>Website:&nbsp;</B></FONT><U>https://www.helius.company/&nbsp;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; color: #242424"><B>Linkedin:&nbsp;</B></FONT><U>https://www.linkedin.com/company/helius-solana-company/</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contacts</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Helius Medical Technologies, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Phillip Trip
Taylor<BR>
</FONT><U>investorrelations@heliusmedical.com</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pantera Capital Management LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ir@panteracapital.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">press@panteracapital.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Summer Capital Management LP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">pr@summer-cap.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --> -&nbsp;</FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>hsdt-20250929.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWa+DSbOdzZR+uYkxtmBxbUlq/yoo90YdSC7AoueW0eEI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:hsdt="http://heliusmedical.com/20250929" elementFormDefault="qualified" targetNamespace="http://heliusmedical.com/20250929">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://heliusmedical.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="hsdt-20250929_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="hsdt-20250929_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>hsdt-20250929_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>hsdt-20250929_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.2b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="hsdt-20250929.xsd#Cover" roleURI="http://heliusmedical.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://heliusmedical.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 29, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 29,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HELIUS MEDICAL TECHNOLOGIES, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001610853<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">36-4787690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">642 Newtown Yardley Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
    100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Newtown<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">PA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">18940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">944-6100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class&#160;A
    Common Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HSDT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2527115d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://heliusmedical.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>hsdt-20250929.xsd</File>
    <File>hsdt-20250929_lab.xml</File>
    <File>hsdt-20250929_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm2527115d1_8k.htm">tm2527115d1_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm2527115d1_8k.htm": {
   "nsprefix": "hsdt",
   "nsuri": "http://heliusmedical.com/20250929",
   "dts": {
    "schema": {
     "local": [
      "hsdt-20250929.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hsdt-20250929_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hsdt-20250929_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm2527115d1_8k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://heliusmedical.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-09-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2527115d1_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-09-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm2527115d1_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://heliusmedical.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001104659-25-094134-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-094134-xbrl.zip
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M*>M=4H$G3"K,_"5\H&:$1?"AFVTN0<E:Z%$&)04T@!6<!-\9\U=7;VA\_;
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M]HR9Y-!,U1'G.(_NP,*^,,KKIE:C+KOWFB_;TJ2I2S^:M\?'+X10-X'7TRH
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M_#HV+%,C()BGZ3#%[$&@W5)8@[?!_YR<EO/('>]O*8] 8_DD^!."E>K1H6Y
M@+HFJ@4&@SJUZE<=CUP>Y;KE1*M^<]WJ;$^4<2D;K:1;OAEQ9T1-E[@6S*1B
M$8#(66)Q(N=WM-V$U2/N@&'3B.NN#AC4)^J FF 5*ZI+H%DN9G,SU'\!]W^.
M]<&("E?;8K;%7;(3?(:0W0"JN(0]0F?"13/3=DN+6JPL:/&-",>"W#-6G4\F
M_=/3R577L _\M&=#??;J.<=)?>*6-)A^"'T'&IU. 5MF+NB['*?O$>R2Y3:S
M898N!,E*<8\@J#>Q YNQ0E!VIOIKP"I;\H6!KBZR5?+9ZN53+=;7'2RIN9A#
MQW/U1^WZ1CZ[G31=R(%\7 7(62D.P%);=P&%'^SE=EQ93O>BZ"7+'^N7C;LV
M:=9KC6KEDG3JU8]7UY?79^#O]TCCJII>2@(C]/;_C"-[US*TEYBMU;9JISZ!
ME8DEH=[QV5((=8AC,Q7S,"VA W-<AX") C7DNUN2Q>UZFN?%PK.1A(Y<ZY#X
ML;&27QL:OT'HNQWZN;1K,."L88 (J;CGD(2H S_;5-."SR\$F3)8#P9$B'60
M_S!+#U3+,*CM "6"OV8CN=X?^$-%TGCD\@"+1\9=K(0&8NDY(C^U/'*UH)^_
M %AW6A'1A/=+1K'VD<DJ'Z(,D;8<:2S-GHRS7+6(Y6J8JL7!=XEM@+8+5K_J
MU<FKEK;"D#D7'WM4YWPRZ#_+2H6\$^Y08(W#93:W'E&WE]Q3=MF,/8EKLEQC
M!AV#HWO21?E_NMHJ#LY"C3#KY ]S25X]]$GF9]\A\T]U@P&5P+_'<_KR:_N'
M;=]VLM]S+_='N65&SN%B=4U.90NYW-.1Q?\XV[(1MG7HI.%7(%6A"T_Q<%B?
M=K^,?XR&I_F7\S"FA+P"B60YNY_*'10.]HO2AAR%'WP[5A<6^&;1YXXP.)@@
M69 8\5#-+O[?-\B;'$T7F540ID:D<+'"L%Y #\DB7<#I_PKQW*E:PZ'NX"$"
M@M4+4&?BL7_76\L"@V,7^XO8V&BUU_(N_*\^M UKRGB$A]L3V96(0JRKA_W=
M[I*4_%0!RKP*[(HU1@T(N;+2\U5Z)(:?&#-N4H9]J^@R5)-^(I9\9=SH5SQ\
M<@4/_;AT\;$7Z 9/??SVBQ^"V=\V P^YI7K$+54TC3/'\7]=ZB:3XUV2>7/]
MO<VOQH[Z"I>TO^R28A!(EO=S"B[;M<8F^4*Y9K ID(!J*YS3WE(95EJS2"5^
MD>>L?2-=6_7A_L'+%WFPR2*59+D]TETFF ]BNJY$\W-EY"".?%7X\YIW@"?Q
MQ'N43\\J9ZS-W/V7$Z^PDGAS\,FR+QL;B\-IW'I$;'#-;R"9 :.](F\Z4^5B
M[<<GK7[V"K$OKES4 @[)\DUEC20\,R@F!^E<_MG1]2LLVP9^:1ZHBQW#MXS!
M8QE_8T$6:WS5[=7I\MWYJ/7-UKX:IO%BMBO22K9',$B6Y4(Q]_,#[TV#4(B_
M?+2QEF=S$%3=I@9A$Z:.7/T12WP0#C!G.=I9(Y_^+T]$EW;O-HE1?D$8#5P3
M:"'K=E=R)PB!WELU<R6/Y^7F?_^KH,@'AP[T-)@]L$Q&3)$G[&%P:XR0 X1R
M1D$3-%9"$F!"L;,JT$##78'NJ[5-J0ZX:52,RN>7;X4JD:V1,,QD69&?+%1T
MR[M+'J/H(W]I@6+=(!&>RM?O[/-/U:\UI_#]>=6UR (B>P"+<)/E8BZ7VM\@
M4OA]1.XJ4]G&B807;TGNG%H<:.AO4W!1ZX2/U#-V(.T]XNV>@OU![TP,Z@2[
MAMO:K(BB_VWD0&HU?1L&Z"9F;B(%JPZ8^B#VBJEM<PML.I9)NM:$=)EAC7'E
MV(CT(874!>GI!BA]0G?  K@,YM%P"]K1AR/#I2:S1HXQ)0XDA$YO*D9Z XC5
MA75Y>:*_-QW:"AK!/$!M<QJT]2 ML\8X#@O,.E8JG-*+=ZJ?3>9Y*AI./1=3
MTY=N='BBN"R(D5P5U&*U6Q=I?^PR$B$7Z<\FZ2:D_S'/P7'J9G0>#."VZB57
MSO0)J(B4=9)+D5K5-[B?N.Z"B&&Q:F3Z108GWNIFBU\N#DS[H=E\GML([[AW
M+<M@U!3GAA?L<60S(Q8M3X *ARM-<O17M'X6RTD?#* ?AD/LT,$/W.[SY#:G
MY'TEBI[Z2.!ACQWY@%1/6T3)2FGHN.O%4R(^B:O/O ]7,=MK_:.+OU(7@^I)
MVS)T%43*[#?!/X"3,.(5\5;[^IC/RYWVS5OH860O:AFE[2OA' 9(B =DA0;*
M.9J2E9 2!N>MHBJ8D])>SS]:^$<+-];"H'9QPQFZ'7R_0ISNQ/B+7_=ZJY*1
MT?GU^7!0O:EH+][J?TH=(]N*JW';OEH"K)0: K:9DY1S6DK9Z>YZGX2F)L*:
M2I8UU1OP1U?_Z.K&NBK'ZVK#<4:,K]78HL*RS5[_LSM\$XW=?T)CES!\-WJ;
M9:G<COH,O?4'_"YZ&SJE[27%C$-:;2\?\?;I,3=B?KH,!"B]3<7GM]R47?="
MT7B@NRR%"V+X=NJ84_M7G_+KX%OFWL%T=4!4@SK.:TY.*4_O[:PET*^E!:>B
ML'S4Y9ERHCT==BUCQUDJL/_/T./*/SLM1(,%1L\R48[5 =;HL\7#N>%X8IMH
M:>&O/9"T7+3Q;=E45KI"IN/=7*=9_]KIF)?3[B"Y'3*]L-(>V:%?Q#U9KJ(B
M>H)3\;=ZAD.@?-NUU(<]\O]26I)D8E-.'JDQ6GUT-4;F5AFS)\1T>]S:][GE
MJYJG8_&LNK#=[%WNY.Q+6_NUK(J<!X@@GBQ_;-<ZOPWQ#Q94)8AC5K][4I-5
M^_)'L_I8./CI/%@\]HT&*.[$MU*,4Z7PVI+ESL [Y7)%'8U^][2(-"E_8"ZY
MO*P^Q<'?;#MU%O(V3+R)!;=4ID05>RTPZ@%,-\-CJ L;(;BM J("L3%.W"=]
M;HW= 4;)-FZ.4(=HK*>;$!SJ9KCZ*^7)\@M_\_?\LF0'.QX<>B7@H+<NWK>Q
M\7T;W/,*!=Q*-Z5L^ KA?&H,O''@TN3IWV$S<L:P9=<=5IQZE#6)@#6!J+XD
M8RQ&3J8$$,X$@*HW_XKS_:>][R?]0?WB7'Z#9#$;<V@E%KE-\\1_C! T>C%:
M&H@"'HV(57E]:=MS  K-#$CM0*%-2R1Z(X>)7H"4O[F*;Q?J8M_4NPD$N2<L
M@C%%X&,=# 1*H GKM7B"LT?=@7%@)JBI8KV:JN+J+.R,MZQIE&N.MZVJ/9EE
M9G=H-,L,JW_Z61(?R,<[%H1GO=OWC'LN0EE$;)81N@?C?;WL]Q8$16P/H??W
M$5: 8%*!N@BTEHFX,AL+%R)E)>9(QW[T'8006N$U^M>B+$'GC#ZDN@S4##"T
M!<9AB/LQ !&+9T(,<_)=,[%;;KAL2/)I*9LFLSNV'+07%8R(#28. T9>[L-P
MXF1JT#'D3H5B[C!1]0P'1"W>E5D$[\Q*O]^#2NA.HZ9-N F-J?X*2]Y.']['
MB&=H@M7Y'E%<Q38S=_KV%@E8!>O<VJS>S\5:^LP57D.V.[]&(.]=([ G',*)
M!;X$X\2:SL%U6-PA._@<2Q**="B:Q=_RX2[*R$=Q-R%I>I<3D@Z#3,(RK+Z.
MJ($ I2/#?5K.)A#GDQ[!90%3:""'*(8X)M09#RPFJIBM]3PWO"B=>QA(]W0#
MIA+>TX]R.7,I%R>0_%?%_/@W^!"\GXJ5E_.1,25R 8DA%Z)81P G(H"#I>PA
MUKXOC4'>.X4&7? F'\N@)IW)%6I,&)HH#7GB%TR>)E&.[?L<2X0@O6;U@$R4
MMC.;\ 0=YIT"-!,!XYYDE*AP 9Z&05BO!S(FQH163:A+"B5)(C0]3),ZQ1*8
M*:0=V;1\_T6:Q-R<DE!RRHZVNR/O!LL^8R;C(*+5D$V[I./55 DOO796O0RQ
M>@%A3?>"/8[7B'+_V-TCP )IB1,&!Y/D@66 M<'D4/.H@3/0.47$>7PG0&]I
M"C\9)_XT8,<A@K1GI^U6\<H[Y8?G?%'K'+*Q0:Q/!GI7=TDV+?M6T--3F,^_
M.3&XD 7H.CM:B(OS(/I4!Z@00L^N%"20,#/=W%8Z^3/.6ZZQK15-$Z$]-8QI
MR*3.3%UB U.'0FP!Y037A'74@+CBY7S-=\(8.#$P6# !$-.(4Z.P_'8&.H_,
MEUB8;VYJ.C!JJ?L2>"&Q74 3X'EJC*\*Z$.\I1;Z 6:TY_K%D#!2BQJ<\#2X
M88J<AFMX9?3<B*':"?#X87YL=)526+Q/3?T']>A/-/\&'2>.#^)19)V)F'7N
M">@A?9WK]ABT)Z3T7A+GC,"VS=B[J)3KR:H[B5=JI_)^M?/- ME"6I+!1XKJ
M6QTO?W+^,7'HC7@SI\4,1IU_9OA9#(>?OD:#EW)&J *@]+A^[JT_8M(BE)E%
ME"#UU#2M$4KO@NT1,>*8@=V"WW'F V_@G>(9>)@#;SA.=;'L8_83!G/1EHGW
MO_%&\%"4Y<5RIP!0\T**,(KSQS/\O.C'8>#9P5[XL\S?N@(P0V'></=CAA@>
MJ=!=X;XQPKF^W(O%OS=R1Q!]V)2[$.HX ]V>(QK"$+5>A?" 0G)CCS@$K4!9
MRQ9M?M#1QUJ6]QI "%#ZS6]Y^S4>.V*C(V+U:GM<+#XG7/J=PJ!55=:U!2+E
MD%P+87-*",J/UP_)W[C;"LUO63]ZUC&Z)RZIBIQU6=Z)>\8Y.?]\V])9N&PV
M>KPAID?NPXJ]R<@E\A[9#PE>&UHB%4Z[NAK<*X^LN;*0X$JD>!6,$C72%="S
M"]"%Y8BB'#ZC]8^LS/T,/9M'.441Y9S.-@%$QNH5[M"D^R9GRZ%/W)V[_ZS#
MJ.F#58=.NX$9#UZ"O;+2<7?EQ!O";KG&')7KPM8]ZWX;\$0!,^?O2F_[Q*/X
MF2V(:QY_6S8_P5$82HGWA0?N4,DK![*<U^1[-LFFY/3 '2;+HI)!-^3FFKE6
MUL\V*(EM5$;%X#7QN@)G3 %1&(YY^AY?7IL3R;O_Y[6*%Z-IJZBK!)Q27L\I
M?ZZU.?A>B"!/42/QL\E1+/K2%HS$LSLI&,VI"KK'/).1+'LQY^O(M2FL2+2\
M1_RT+>Z.X@C5WH!HLI3;;,'+QP#P;SPTS(?4\,.Y,?-N0\E)@9.?!_K! -W4
M71U'+%X9C%^.<TBZ$*+V.:9=&$):'$*D?G='R>-VB_]C%PR'!01(B)BD@>$;
M]02O1EW(*O$2MQTDI*;Y>@\I&^IW0WQK&,&O#2/!/=&[<4>K2.ATU>\1[[PX
MK\C^22%^:0J1_9-";%O<WU_Q<O77DS3.KBJ=NU;]_19>8TF]?'M&>#/1.]PE
MZOLBT=KP .5>W*DP#?>753IRQ-Z#[OA7C2"8+B,.( 4-EG=G>I<-J-'#6CQ.
M).I*?@>LR(],UTJ(Z>C('5@<[(;V1C7Z=_VND)< ^&>ZY[=AXGCTA,=)18CF
M!E?K=Z-><U.8"P8M+SW]2DK0;:->N85NS\5MB^^KX!=/"$?@1W4>5O/0;OE,
M_A:!GTQ+3YWZ7_#JW:A7W^9;.QDG0\XA->!LFFBG29."$C.'F<^\OBW*I!@Y
MR+P%%7W$R<]"_/5FJ I(]D+5KFMQ"QV'4=S[MC4NDK=9#KQ\$?#6WBIXUV%O
M+E1.O\0;K/[$OC\_]LW]S-CW%Q:S-_EZVL+)O3CI[IW4F'VK+3N?G'[3ZA?C
M;Y5FJUOL9R:U_<M+Z^\3;?CM2\[*?;T=MS[OCR[OW"E]^+NKW3C#C'OEW-Y*
M_48QGU<;[:_ZK>)J#?4J__>GUGAR^=TVZDVKT*#-/(3^#Y\FV69OH.5.Y>ZD
M\#V7ZTU/JI\?SFZZUU_:ICD9#T^*](MKU*Y/]5,];ZK]?.OT9O3U0/I\NS\>
M?AU.#UK7%]+WNPM:-R^,P;>[_.0JF\M]M[\T94VZU>XNE.'#N"EU;M7\;:;1
M/#\?6^?:?OU'P?EZ^J#W'>.VK_7'-ZW'Q[8Q^FCKZH!W:XKZF3YD)G*A<LON
MVE;._R+C#'X9K_@N:7=HE/\+4$L#!!0    ( #!#/5L>POEFS 4  +X@   5
M    =&TR-3(W,3$U9#%?97@S+3$N:'1M[5IK;]I(%/V.Q'^XB[15*O'>9M4%
MBL3#":X(1N"VZL?!'L/LFADZ'H>POW[OC&WB4C9)L\DV;1J)&#RO,^><>V?&
MT!FY%^-NL= 96;TA7D'_=5S;'5O=3BVY8FDM+>[TG>%'F+L?Q]:;4B"X:D&C
MOE'@LC6-8$*W,!-KPLO)C3+,J61!"1MBTVG6;DWDDO$6U$O=%WP1;=J=VO2@
MREV[;L.^,ZQ:;X.B5ZI"0K;$6Y(M5ZK4[?2[UM6*+9A*1ONMVNC4^MT'&_21
M9^%1KJALPX)X?RVEB+E?\40H9 NV*Z:HF=_ FKGVF3WHN18X9]"[L"9#?+G%
M@NN .[(>=+[_&9X]&3BSJ3/KN;8S^<;0$,[(&MOOYG!A#1'A&%QK,)HX8^?<
MMN;E1%D$7/VA+',RC644$ZY ">S/4TSP!%'S5;-8$ &H%85SRJDD(0R$W A)
M="48DRVDQ7-%%-4?AC0D6R+IR^^%GS_C2+%@E]YDW*>ZTWKUE/&;W'+F3-P\
MCDK$_J8)F#:8&Y=$,J+[BM8D#"L>V43&92,:LC@J%BZHSSQDU*7>BF/G2X:
M4X]Q+_68'D8WRBCH=T\TW2]"_U,LVEC0L;LY23HUNZLKO9"F_&49"'@YQ81<
M$HY ?2#<!WK%<.Y\62S@!*DT]Q:[9*A+)E5,X9[J@T&9P$NQ#L\'XQ16AA+A
M^0)E6U%)%SMTJM1*% MJ153K^?K'N.3,GLW=5LX$R23<%2T6.%GOE<DKPB)(
MS 6W>.OAN/@^R9U; V<R;.F]S)Y?]X#,+8F \2QX,&*2&-&<&_[OQC1L<LF5
MZ !D.%<=2<;LV%11DV-MGH_3@(4XXI:I51)?U)-4$;G3JN^#[7CD8>NW<9A&
M<>-U&9KUQFLXP=EL)+UD(H["G<X)$C-]F@>P+(H7$?T4([TA!B#.#R?K0R#%
M&A2*I='K:QF^S#[7$X'#>1RFH[8>[IE[SQW9L^&_!'9?$.D;-9F61\CH2)AC
M3O=TUD9WXCMDVR?<H]=FV4AQR2*L:!JG"WH$C5<-(S8NZEFG.B5C;[[8:"=(
M&HDP-I53!^A!S. W2*S-$X@P%-OH!T_9,VONC-];PW*R0$$/2?%"FL;Z7JB;
MN#J>L]/E+PLZ+1)JH4S208V9B@ !HB/4[OFPG>:8@_4.V?(^)V\N0L()4KK>
M$+Z#8[LC4W*8BJH_-GVW[R^<=S-W="P/,0S_ Q?WM#7Q95:Q6UT>K7"_"PL*
M- AT]KFDVK98[76K7D]&(=5U-7EGD0B/)SQ99;#QG&(R6B^H3(\@?V"X->O-
MTV>LURWG"9L7"Q^8XC2*X(/.)2+(J5J^ZT9EA1IY)(XPZ9@XN\D"BS3KT2OJ
MQ3I-8?K"-%4L^+CS !*K%>YS]"E#!-@#[II06--I\Q07*9_H?4S2PUYNO4]Y
M5)7=7G]LP< :CZ>]X=">G+\IU4OF\WS:&V2?OWK0!:Z_5&HU0Q0$%<O>M7%%
M]M5*]U+_M62>IG7<V=</<*EU0.$R?RV$4F)=2A_/==SAUS^!^])L 5FS<->Z
M#<L7B23C.#FFUMQA#M; T<Q.WI2:![1>^_=.!.2#*Z2!>DC\=XN-_/SPW^P)
MB;EWV:DVV?\C[+TA/EV$AQ[;8W[UV*"?F)^^&X4>$F@?V]P(,TWR";LMZ(>X
MC$,#0>.)B?E)C_>=1BVJP5O<*4FZ@WD5+@@NE#2B_*?IOK7I'A+6!(\PK4<+
MA:/^^2GTMX#E,A4^HM(#%#> ,\8)]QCN6)QD@XT-)251+-.G^/L'A@<NJ)E=
ML-D0/\635.GZ6[5?*A6<)@W]%DS)$G?3<_-XTM-$M\'9F.=4+=UO^H0+QGB2
M;,-[$L:Z#E0J&?-#^_WGWS97E-A@E:8^6J5WLM3^N[YW<[I'D/>8Y[&OY/)H
MZD? )&?U![-FGM.,S3:XNPW6Z$FR8%X;3)XRC$^$IK"1;U3+6NF2O<6G^$**
M,[;S]74_B1"/X;::_OU!\H,$_;N%?P!02P,$%     @ ,$,]6T_,_I1\>0
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MQWDV$3TC<MOCAXLE?%B17"$53CSXDZ =)/Z8[C/K>L[8K9C%#P=PL8$# 8\
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M@:S;S-(5DU7W(TDZK44Q_-(]&^D5$4^)52&":CL1S**;*.U7A2/_O+A)VN$
M<;CK%&+=XN;P[S0(K]<HV>(6;3 IT<<[)X&Q5-R)[6ZN<X$0"\*/K)]._-(P
MCV()%*@Y&S[)-@N>^!9BHCPYE?!HB=:E_A_=3'\6RS)GU0)) "/;!'"4D?1-
MT?\&\GM\;B;+F:P;=(T:A:K.H&U2N*"6T.0Y: N4)'<&-):/=/=B2Q)OC7L$
MIS_"Z--\S@DO20["C_+!.8*?'""_^XSQ4=(*O*\.K>$DF>Q48=R3RI[Z05]*
MJV8O,H?XR=,D#K!F#OV<&*\D]_@ANV:Y'&>+^'G/KG;0?!X;#HMX2063AFDG
MX3^RB/P3WV%%9#,'U].]@^N*'5R/]PZNF]2G+W:@:.[:%6@/3,:Z(JCJPA-.
M-G50V2RG4(OV%G<8:2C99:RQ[6@C0XE:N)(T@3P7*X%6E+C-V=8<QG?92\-!
M1XH01MBH/*K"-\*2=+[J@Y/,1JY9(UMT8I(#=+&@ER2H$K%&9Z-*A"8\!A'/
M^2XS%*YUL\3$6:S-&A//OU-+CBAO@<L )8^/'6'D!]4SOWB8;*NLM&. +-'D
M4JJ H?@>J(&JS<1!?(I/'*:;9-,I".T<V$%@3?=FRD5R'HE*-DEZ;!E6I+P3
M,@ +RQE5TZ%3@/\:22YDD/U(E5XV.5+R!]WN@=WE97YB%97(;\^I^WAR[W'4
MJ8N"?"%&1?!2GD>0BL9A,KL?X<+1JNE;.=\BR?G4FW!.:2,$]4BN$L[-;-TD
M\L((3 $I31JJ7];+TF#-XBOU)X(NVDXZ]%+WTK+$"*_ZJ\)XZ($6Y!>(4,!Y
M+,B6X+O#5L*""S*VK]VI 2/#<*I:.B_$@>6\0,H0Q-6$X"NSC+-7X8&J*L;T
ME^,<M,5-9Z'<B^JPS4=& 73+<.".?L.]&&E*EC7NO*R2@V.;,=E(E+3&J>,.
ME.$K&B1='*%C=((VSWFD$ 0(PR+ULZ/P%C;I:I.:2DY.) HC;D$N-L>,3U<2
M&VD\ZF?!DQ5@G]#R8JF,=7$7$1NMNMM4O^&#Z!%HAT0T\(@X2Y/ ;:T.QJM]
ML;P9#O:UNT?-%%BYOT:<I\$1N_1:#+&[_28R)'0R@M%@JP83?!:R$ILU.G)I
MI1I[D<0T3&3P,A^_Y^S$.55YTZGA*L'H-FE5-PR2[F)[*QR 9 05!>G+CR'
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M)72P4%/%@(RX\.,M">F8%I(/0N/#@!-S6MLL9HH1P=.G!<8:X:U$]>AL4^X
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M[X$KWD^7-9C^<)X3SX)HFMQ<F&\^9Q6G&''!O&:@*M(M=CN(C 8&K.VO20T
MK!GNS3FKO-3;[K:S=(H3]H<<WG)V9V_8Z0XT<(GLM: NV0S\6D!>1GJ*DV0!
M]I!Q*+_J)*GXSCKTE=^Q1$Y'LDF [0&!J%LC>EG[H_7%>#SI,55I^N *7EN
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M!>A#E.L7@^NRW-QRZT#AX6M[Q_2.+[07;A !Z[T[D] */?).A\Q"/CW-F:<
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ML*9;96(H#1'A),^,Q5Z/J4(L_N^* W$7\E,14([N"2N(,9O80YC"4Q3Y/U>
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MH>"\:I*%J[T\/,?\5*B./W:#(0C<I%BL:87#G7.B$PE*04,'^DC3\DG@PCF
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M<$!LE+"_R9D\X\*28);3)?HJ>V;9@.>U[2N"DD'6R5W?]-:[I7MH+B4TML;
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MH7X?3H\M0E?>(@X K0#6J=7I)T/?GYN9@T%Q(UJ!LW8+AP/=PR:.-K$A08=
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MWBK[25H]#+_&]#\]FL$MEO#*7.E _4#M'!N';+9I:(8#R%VJ %>BPN9+@&F
MT "YD^L-)P)FI> U,F13TXN)BNBXU?%""\(^^,4: !EI$27Q7D0N63.@AP(+
M&47$&@Z<U)DX!8EX9:S*E<Q&(1^IX8)NKR!B06]>!"@C92\D507H*.O@9B*1
MP;<Z%4?9E7;$A0SCR,-R]DWOR,!OF-)W'<)P\"N%ZMXZA,EV.8RZ420P=B?H
M 'Y+YW M)DZ,*XWX08.WC<3?%7P/5[=1 .UNBX) 5M\D3MFKL.KAA<"6S5M6
M3_:CA,_D>B1Z5?HN'LST^J[&O%<047!SLTJIFA*P<KP0@:$"<J53CA5==?%
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M]B*F)@_^L?X"]81G^*])8HG/8@]SZ37W,R"X#R/R.OE_&(_%"PJ7?1"BA3J
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M,3$U9#%?97@S+3(N:'1M4$L! A0#%     @ ,$,]6^YHYG#3#0  %S0  !8
M             ( !DZP  '1M,C4R-S$Q-60Q7V5X.3DM,2YH=&U02P4&
/  < !P#/ 0  FKH

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>tm2527115d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hsdt-20250929.xsd" xlink:type="simple"/>
    <context id="AsOf2025-09-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001610853</identifier>
        </entity>
        <period>
            <startDate>2025-09-29</startDate>
            <endDate>2025-09-29</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-09-29" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2025-09-29" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-09-29" id="Fact000005">0001610853</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-09-29" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-09-29" id="Fact000011">2025-09-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-09-29" id="Fact000012">HELIUS MEDICAL TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-09-29" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-09-29" id="Fact000014">001-38445</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-09-29" id="Fact000015">36-4787690</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-09-29" id="Fact000016">642 Newtown Yardley Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-09-29" id="Fact000017">Suite     100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-09-29" id="Fact000018">Newtown</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-09-29" id="Fact000019">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-09-29" id="Fact000020">18940</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-09-29" id="Fact000021">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-09-29" id="Fact000022">944-6100</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-09-29" id="Fact000023">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-09-29" id="Fact000024">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-09-29" id="Fact000025">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-09-29" id="Fact000026">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-09-29" id="Fact000027">Class&#160;A     Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-09-29" id="Fact000028">HSDT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-09-29" id="Fact000029">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-09-29" id="Fact000030">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
